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BIOMIMETIC CRYSTALLIZATION NANOLITHOGRAPHY: SIMULTANEOUS NANOPATTERNING AND CRYSTALLIZATION OF OXIDE SEMICONDUCTOR USING
UREASE AS A TEMPLATE
by
Kristina Ivana Fabijanic

Advisor: Professor Hiroshi Matsui

Recently, there has been a heightened amount of work done in the field of
biomineralization. By taking inspiration from natures’ phenomenonal individualities as a
means to develop new and interesting nanostructures of varying sizes and dimensions, there is a
newly developed design, namely Biomimetic Crystallization Nanolithography (BCN). With this
method, the simultaneous nano-patterning and crystallization has been achieved using urease as
the nucleation point and the hydrolysis of urea to obtain patterns of oxide semiconductor
material, namely zinc oxide, at room temperature and aqueous solvent. The new and interesting
characteristic of BCN involves the construction of amorphous inks of ZnO through the use of an
enzyme, its hydrolyzing abilities, and Zn-precursors. These inks are nano-patterned with the tip
of an atomic force microscope, which has found to induce the crystallization of the amorphous
inks into crystalline patterns.
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Also, a micro-contact printing (µCP) process was developed and utilized as a means to
directly pattern enzymes in a single step without the loss of enzyme activity after printing. By
modifying the substrate to display aldehyde groups, the direct stamping of urease enables the
simultaneous patterning and covalent cross-linking of urease under the reducing agent
NaCNBH4, which does not degrade the enzyme activity. The exposed urease particles on the
substrate, free from the cross-linker, were still catalytically active and utilized to grow crystalline
ZnO nanoparticles on the enzyme patterns in ambient conditions and in aqueous solution.
Recently, there has been a growing demand to have the ability of fabricating
nanosized structures that are 3D in orientation, produced in large quantities and yield uniform
shapes and sizes. Biomimetic assembly has been given attention in that it relies on the use of bioinspired materials that are characteristically organized from the macroscale all the way to the
nanoscale. Peptides are one of nature’s building blocks that have the ability to take an active role
in self-assembly and that can further be integrated to consequently yield the self-organization of
structures with interesting properties in high quantities. In this study, first, micron-sized
assembly of streptavidin-functionalized Au nanoparticles and biotinylated collagen peptides into
cubic structures was demonstrated as assembled peptide frameworks incorporate nanoparticles in
the exact position of unit cell, and then other fluorescent molecules or nanoparticles with biotin
moieties were co-assembled to generate complex 3D nanoparticle assemblies. Energy transfer
(FRET) and excitonic lifetime change of between QDs (donors) and AuNPs (acceptors) in these
assemblies were investigated. As the interparticle distance was changed, the FRET efficiency
also changed, shown by emission lifetime measurements. The energy transfer efficiency was also
affected by the number of acceptor nanoparticles around the donor QDs. This type of robust
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large-scale 3D material assembly technique with precise positioning could be beneficial for
future bottom-up device assembly such as solar cells, batteries, and metamaterials.
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PART I

CHAPTER 1

BIOMINERALIZATION FOR FABRICATION OF OXIDE SEMICONDUCTOR
MATERIALS VIA NANO-PATTERNING TECHNIQUES

1.1 Introduction

Recently, there has been an immense amount of interest expressed to successfully
fabricate novel and functional materials through environmentally benign routes and
methodologies, specifically room-temperature and aqueous solvent. As a result, it is of no
surprise that focus has shifted in implementing the exceptional mechanical properties of
natural/biological materials1. Some biological materials, such as starfish and sponges, have
evolved amazing abilities to synthesize interesting inorganic structures in benign conditions with
incredible precision and complexity at the nano- and microscales2.
Taking inspiration from nature, biomimetic routes have been implored to fabricate
technologically relevant material, such as oxide semiconductors. Oxide semiconductors are
materials of great interest because of their inherent wide band gaps and large excitation binding
1	
  

energy3-6. Although many promising advances have been made, it would be of great impact to
use a biomimetic-type of approach as well as a patterning technique to integrate these
biomaterials into precise locations and then rely on their inherent biomineralization abilities to
produce interesting and applicable structures of specific dimensions and shapes. In doing this,
there is more promise for their potential integration in electronic components of complex circuits
and microprocessors7, energy-storage systems8, solar cells9, optics10, and sensors11, in a more
cost-effective and environmentally friendly manner.
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1.2 Biomineralization of Biomimetic Materials in Nature for Ultimate Crystallization
	
  
Biomineralization involves any and all kinds of living organisms that have the ability to
take any metal ions found in their environments and, in turn, utilize these metal ions for specific
functions while simultaneously forming them into a wide of array of interesting and phenomenal
structures. Based on the mineral(s) that these organisms produce, they then precisely tune the
incorporated inorganic ions as a means to control their own needs and to enhance their functions.
As a result, these mineral-inorganic nanocomposites form into various structures with specific
sizes and shapes12. For example, the teeth of sea urchins actually contain these calcite (CaCO3)
rod-like structures within an amorphous CaCO3 matrix. Furthermore, the vertebrate tooth
contains both dentin and enamel. While dentin contains collagen, similar to that of bone at the
nanoscale, enamel contains amelogenins, which can spherically self-assemble themselves into
rope-like bundles 13-16.
There are a larger number of biomineralization processes that involve the formation of a
highly hydrated amorphous phase. This amorphous phase can then be further manipulated and
crystallized to yield complex shapes in vitro through the transport of precursors controlled by the
topology and chemical functions of biological substrates17-21. Aizenberg and colleagues have
identified a transition state, namely ACC (amorphous calcium carbonate) that can very quickly
crystallize in vitro into polymorphs, which is the ability of a system to crystallize into different
crystalline forms. In nature, ACC crystallizes in the presence of various amino acids and ions in
a specific orientation and so, in taking direction from nature, in order to produce stable ACC, one
must use phosphorylated amino acids22-23.
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It is clear to see that many of natures’ phenomenons are just that- they can manipulate
their ion intake and when combined with their innate minerals, form interesting crystals. In
order for us to understand nature, using a biomimetic approach can teach us many things and can
lead to the development of innovative and technologically important materials that are applicable
to a variety of industrial fields.
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1.3 Enzyme as a Nano-reactor in the Biomimetic Route for Crystallization

	
  
The ability of hydroxide intermediates to undergo condensation and dehydration in a
basic aqueous media and low temperature has been the focal point for previously synthesized
oxide semiconductor nanostructures41-44. Previously, an extensive amount of work has been
done utilizing certain biological templates like DNA, peptides, and proteins for the growth and
development of various metals45. These biological templates have been favored for use due to
their inherent abilities to control pH at the molecular level of the system46. Although this is yet
one more of nature’s outstanding phenomenon, many times the ultra-sensitive systems of these
biological templates is not favorable due to lack of control. Put more simply, the local pH may
spontaneously change due to conformational changes in folding or assembly intra- and intermolecularly. As a result, these sporadic changes make it problematic to control reaction
parameters in order to arrive at one conclusion regarding procedural protocol.
In taking the advantageous amorphous-crystalline route from nature, it is necessary to
find the biomimetic material that is capable of providing a means to synthesize material of
technological importance, such as oxide semiconductors. Ulign and colleagues in 2006 reported
the shift of interest to utilizing enzymes to generate mechanical responses that can ultimately
have an incredible advancement in terms of drug-delivery and regenerative medicine24. Smartmaterials are those that can alternate their properties based on their response to external stimuli,
such as temperature, ionic strength of the solution, or small biomolecules25-34.
As previously published by de La Rica and colleagues, enzymes can be used as the nanoreactor responsible for the room-temperature growth of the semiconductor oxide, zinc oxide
(ZnO). By using urease as the biomolecule, it was found that the local pH around the enzyme
5	
  
	
  

	
  

particle has the ability to be controlled through the hydrolysis of urea, by the ultimate production
of ammonia. As a result, an oxide shell is expected to grow in an encompassing manner around
the enzyme. The hydrolysis of urea serves to finely tune the pH around the enzyme, which leads
to creating an attractive environment for the metal ions, which ultimately allows for the
production of the oxide semiconductor35. Additionally, it has been investigated that urease has a
particular high affinity for metal ions so it has the ability to interconnect the semiconductor
precursors extremely well when placed in their presence36.
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1.4 Nano-patterning of Oxide Semiconductors for Ultimate Nano-electronic Integration
	
  
If the amorphous phase of an oxide semiconductor material (e.g. ZnO) could be secluded,
nano-patterned, and concurrently crystallized at room temperature, the resulting semiconducting
structures could be applied to many applications in the nano-electronics industries with low cost
and environmental impact37.
There has been an extensive amount of research in terms of various nano-patterning
techniques to produce arrays of different materials of interest by imploring a variety of top-down
techniques. For example, focused ion beam lithography has resolution down to the nanometer
scale, but may result in defects that can only be resolved at high temperatures47. Similarly,
electron-beam lithography (e-beam lithography) has gained a commendable amount of attention
due to its ability to achieve patterning down to 75 nm. The problematic component of such a
method is an economic issue that needs to be improved in order to be applicable to industrial
wide-spread use48.

Mirkin and colleagues, on the other hand, have developed dip-pen

nanolithography (DPN), where materials such as molecules and polymers are written as inks by
using an AFM cantilever as a pen. It is through capillary transport of molecules from the AFM
tip to the substrate that DPN is used to directly “write” patterns. These patterns contain a small
amount of molecules placed at specific nanometer dimenions38. Similarly and perhaps even
complementary to DPN is a technique designed by Whitesides et al., known as micro-contact
printing (µCP). With this nano-patterning technique, an elastomer stamp can be used to directly
pattern various substrates with the material of interest.39 Although there have been some
significant advances utilizing these techniques, it would be advantageous to have a method that
7	
  
	
  

	
  

is cost-effective and can target specific areas on a substrate of choice rather than covering an
entire only to remove it prior to use.
Despite the many interesting patterning techniques that are utilized, the one important
characteristic missing from all of them is the ability to cause the simultaneous crystallization of
an amorphous material while being able to simultaneously pattern the interesting material of
choice from the micro-scale to the nano-scale.
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1.5 Applications
	
  
The interest in biomineralization of biomimetic materials has grown exponentially in the
recent years due to the phenomenon that takes direction from nature to produce interesting 3dimensional crystals based on the formation of mineral-inorganic composites. In order to
produce material that has various uses in nano-optics and nano-photonics, in would be of great
interest to implore nano-omaterials, such as enzymes, that can lead to the crystallization of oxide
semiconductors. Furthermore, in coming up with and utilizing a nano-patterning technique that
can induce the crystallization of an amorphous state, this can lead to an interesting advances in
nano-photonics
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nano-optics.
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CHAPTER 2

BIOMIMETIC CRYSTALLIZATION NANOLITHOGRAPHY: SIMULTANEOUS NANOPATTERNING & CRYSTALLIZATION of OXIDE SEMICONDUCTOR ZnO USING
UREASE AS A BIOMIMETIC TEMPLATE

Roberto de La Rica1, Kristina Ivana Fabijanic1, Antonio Baldi2, and Hiroshi Matsui1: Angew.
Chem. Int. Ed. 2010, 49, 1447-1450*

2.1 INTRODUCTION

2.1.1. Biomimetic Inspiration

Within the last 10 years, there has been a growing interest in using nature as inspiration
to create technologically interesting materials in benign conditions (i.e. at room temperature and
aqueous solutions). Although this newfound interest has resulted in the development of many
new interesting and technologically applicable finds, it would be even more beneficial to the bioinspired field to find a way of being able to pattern these biomimetically synthesized materials
into preferred shapes, dimensions, and proportions. In being able to achieve such a task, it would
prove beneficial for their integration into electronical components of sensors1, solar cells2,
optics3, and energy-storage systems4, just to mention a few.
*Permission for use granted by License Agreement (License # 3315490059016)
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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Furthermore, it has been shown that many of the biomineralization processes we see as
examples today have been shown to include the formation of a sort of transition state, a “highly
hydrated amorphous phase”22. Upon further manipulation and tweaking of the system at hand,
said system can undergo crystallization to yield complex shapes of varying dimensions in vitro.
This simultaneous crystallization results from the conveyance of necessary precursors, which is
ultimately controlled and affected by the topology and chemical functions of the biological
substrates5-9. Furthermore, if the transition-amorphous phase of the biomimetically produced
oxide semiconductor could be secluded, nano-patterned, and crystallized at room temperature
and aqueous solvent, there are a vast number of applications this development could prove to be
advantageous for, such as the nano-electronics and the nano-optics industries. In addition, in
being able to achieve all the aforementioned results, it would be beneficial in terms of cost and
environmental impact.
Although dip-pen nanolithography (DPN) is promising in terms of being able to pattern
at the nanoscale for a variety of applications, there needs to be a nano-patterning method that can
take full advantage of the amorphous phase in biomimetic systems and allow for the
crystallization of said system to yield mechanically interesting oxide semiconductor material, all
the
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while

done

in

benign

	
  

conditions27.

2.2. ENZYME AS BIOMIMETIC NANOREACTOR FOR GROWTH OF OXIDE
SEMICONDUCTOR MATERIAL

2.2.1 Urease as Catalytic Template

The synthesis of oxide semiconductor material, such as Zinc Oxide (ZnO), at room
temperature, is an important research goal for many industries. This notion is attributed to
a smaller consumption of energy (a more green alternative), a more profitable cost of
production, and less manpower10.
As previously mentioned, Ulign and colleagues, in 2006, reported the shift of interest to
utilizing enzymes to generate mechanical responses that can ultimately have an incredible
advancement in terms of drug-delivery and regenerative medicine11. Furthermore, there has been
evidence as previously reported, that a particular enzyme, urease, can be used as the nano-reactor
responsible for the room-temperature growth of the semiconductor oxide, zinc oxide (ZnO) 12.
By using the biomolecule, urease as a nano-reactor, for room temperature synthesis of
oxide semiconductor nano-shells, it is fully advantageous in the sense that the local pH around
the enzyme can be easily controlled as a result of the hydrolysis of urea. It is well known that
urease is a high-specific enzyme that is able to generate ammonia and carbon dioxide through the
hydrolysis of urea31, as shown in Figure 2-1. The local pH around urease allows for optimal
growth conditions for oxide semiconductor nano-shells, by means of this production of
ammonia.
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enzyme particle can be controlled by the hydrolysis of urea
(Scheme 1). Mainly, the production of ammonia by the

Scheme 1. Hydrolysis of urea catalyzed by urease.
Figure 2-1 [12]: Hydrolysis of urea catalyzed by the enzyme, urease

enzyme
finely tunes the local pH at the template surface
The ammonia then pre-concentrates itself, encompassing the urease, to yield an increase in the
such that
it is adequate for the growth of oxide semiconductor
pH. Furthermore, urease has been seen to have a high affinity for metal ions, which allow for
(Figure
1). Urease also presents another advantage in having
efficient interpolating of semiconductor ions . The combination of a high pH gradient
high affinity
for metal ions, so that the particle will intercalate
surrounding the urease enzyme, with the ability of the biomolecules to interpolate metal ions,
semiconductor
precursors very efficiently.[9] Thus, these
allows for the synthesis of oxide semiconductor nano-shells encompassing the enzyme through a
13

biomineralization fashion12.

[*] Dr. R. de la Rica, Prof. H. Matsui
Department of Chemistry and Biochemistry
City University of New York—Hunter College
695 Park Avenue, New York, NY 10065 (USA)
Fax: (+ 1) 212-650-3918
E-mail: hmatsui@hunter.cuny.edu
[**] This work was supported by the US Department of Energy (DE-FG02-01ER45935). Hunter College infrastructure is supported by the
National Institutes of Health, RCMI program (G12-RR-03037). R.D.
also thanks Drs. Masahiro Kawasaki, Irene Piscopo, and Jorge
Morales for assistance with TEM, EDX, and HRTEM.
Supporting information for this article is available on the WWW
	
  
17	
  
under http://www.angewandte.org or from the author.
	
  

2.2.2 GROWTH OF SEMICONDUCTOR ZnO NANOSHELLS

In order to shed some light on the accessibility of synthesizing interesting and applicable
materials, specifically oxide semiconductors, in benign conditions, de La Rica et al. synthesized
ZnO “nano-shells” around urease biomolecules though a biomineralization approach12. ZnO is a
prototypical oxide semiconductor with a wide band-gap and an ability to grow in a number of

Angewandte

interesting shapes including, but not limited to nanorings, nanobelts, nanowires, and

Chemie

nanoparticles. These materials were grown due to the notion that each of the above-mentioned
shapes of ZnO was able to yield material of inimitable electrical, optical, and catalytic
properties14-21.

DOI: 10.1002/anie.200801181

The crystallization and synthesis of ZnO nano-shells around the urease biomolecule in

r Growing
Crystalline
attake place at
benign conditions
was achieved taking ZnO
full advantageNanoshells
of combinatory reactions that

i*

the surface of the urease nano-reactor with a subsequent step for the synthesis of oxide
semiconductor materials.

iconductor
y, as mild
consumpd compatit factors in
r nanopare in basic
d catalyze
intermedias DNA,
w various
pH at the 18	
  
sensitively 	
  
e template

Figure 1. Synthesis
of ZnO nanoshells using the enzyme urease as a
Figure 2-2 [12]: By using urease as the nano-reactor biomolecule, ZnO nanoshells have
catalytic template. Step 1: ammonia, generated by the hydrolysis of
been synthesized. Step #1 shows how, upon the addition of urea, which undergoes
urea,
adjuststhe
thepHpH
value tuned
around
theenzyme-solution
enzyme. Stepinterface
2: after by
addition
hydrolysis,
is finely
at the
the generation of
2+
growth
of ZnO
is ZnO
catalyzed
by the
local
pH
of ammonia.
Zn , theStep
#2 shows
hownanoshells
the growth of
is obtained
upon
the addition
of Zn2+
precursor.
value
at the enzyme/solution interface.

precursors are preconcentrated at the	
   enzyme where the
chemical environment is adjusted at high pH, suitable for the
subsequent semiconductor growth process.

The combinatory/coupling reaction, as shown in Figure 2-2, is the result of ammonia production
at the enzyme-solution interface. The ammonia is generated through the hydrolysis of urea by
the enzyme urease. Subsequently, the basic pH gradient allowed for the growth of the ZnO
nanoshells in an environmentally-friendly manner upon the addition of Zn-precursors.
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2.3 BIOMIMETIC CRYSTALLIZATION NANOLITHOGRAPHY

For many studied systems that undergo biomineralization, these processes involve
the existence of a highly hydrated amorphous phase, as previously mentioned. This transitory
amorphous phase can eventually lead to the crystallization of the system in vitro by some
influence – namely the transference of necessary precursors within the system. The movement
of these precursors is actually controlled by the system utilized; the abilities and functions of the
biological substrates (system) are responsible for the movement of precursors to certain areas
leading to the synthesis of interesting materials22-26.
If the aforementioned amorphous phase of the ZnO material could be isolated,
nano-patterned, and crystallized at room temperature, then the nano-electronics and nano-optics
industries would profit tremendously due to the potential for low cost room temperature
synthesis as well as the relatively low environmental impact27. It has already been demonstrated
that the crystallization of ZnO could be achieved at room-temperature and aqueous solvent
through the use of urease, an enzyme, as a catalytic template12.
In order to isolate, nano-pattern, and crystallize the amorphous phase, focus should
shift to the field of bionanotechnology. In looking at current available methods and not being
entirely satisfied with those already in existence, a new lithography technique has been designed
and developed, namely biomimetic crystallization nanolithography (BCN)27.

This novel

technique was developed as a method to, not only fabricate oxide semiconductors but to have the
ability to pattern them as nanowires on silicon at room temperature simultaneously, as well. The
distinguishing characteristics of BCN include the ability to yield relatively stable amorphous inks
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ZnO, which are subsequently nano-patterned using the tip of the atomic force microscope as
allizationof Nanolithography:
Simultaneous
the pen, and ultimately crystallized by the AFM patterning process itself. The concept is
nd Crystallization**

comparable
to dip-pen
nanolithography
(DPN)
in thatMatsui*
conventional DPN uses materials such as
Kristina Ivana
Fabijanic,
Antonio
Baldi, and
Hiroshi
molecules and polymers as inks and the AFM cantilever as the pen28. However, the innovative

microscope for a pen, similar to dip-pen nanolithography
uch as starfish and marine
(DPN),
and materials
the simultaneous
of states
crystallization
ability to synthesize
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characteristic of BCN
is that
in their induction
amorphous
are usedwith
as inks whereby the
the AFM patterning process. In conventional DPN, materials
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as molecules
polymers
to be patterned
are written
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patterningand
tool.
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the writing
process asitself induces the
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al crystal growthconcurrent
process, have
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crystallization
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material
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(Figure
2-3).
with reduced cost
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crystallization of the amorphous material to yield semie great success of this bioconducting nanopatterns (Figure 1). To draw crystalline ZnO
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ons for their integration in
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Figure 1. Schematic of biomimetic crystallization nanolithography
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hydrated amorphous intermediates are required
as inkwells
for the writing on the substrate, and these amorphous inks are
produced by the enzyme urease, which becomes the nucleation point for the reaction. After addition of the enzyme

As a means to successfully develop and pattern crystalline ZnO nanowires on a Si
substrate at room temperature and aqueous solvent through the use of biomimetic crystallization
nanolithography (BCN), the enzyme urease is employed to yield the formation of the
aforementioned amorphous transition state (which eventually is used as the ink in this writing
process) which serves as the nucleation point for the growth of ZnO. Once urea is added to the
immobilized urease, the production of ammonia that follows is deemed responsible for the
increasing pH of this system. It is this increase that provides the hydroxyl groups that allow for
the growth of ZnO nanoshells around the biomolecule, as seen in Figure 2-3a. Each urease
biomolecule then creates an individual neutral pH gradient at the enzyme-solution interface. This
pH gradient results in the formation of the nearly neutral amorphous intermediates on each
urease (4,5 our paper), as is seen in Figure 2-3b. Following the generation of this amorphous
ZnO ink around each urease (Figure 2-3c), the AFM tip is dipped into said ink and used for
nano-patterning the Si substrate with desired dimensions. As shown in Figure 2-3d, the contact
mode writing process is responsible for the crystallization of the amorphous ZnO ink to yield
crystalline ZnO nanowires27.
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2.4 RESULTS & DISCUSSION
2.4.1. Simulation of pH Gradient of Urease

As previously mentioned, the creation of nearly neutral pH gradients surrounding
each individual enzyme results in the generation of low-reactivity intermediates that leads to
each urease being surrounded by the amorphous material 29,30.

Figure 2-4 [27.37]: Simulated pH gradient from the surface of the enzyme to the bulk of the
solution. The numerical simulation of the diffusion pattern was carried out with a finite element
method (COMSOL); urease is depicted as a cube of 11.5 nm side sitting on the substrate surface

In order to effectively compare the analytical value as calculated for the pH
gradient, a more accurate numerical representation of the diffusion pattern was carried out with a
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Finite Element Method (COMSOL), as shown in Figure 2-4 above. The enzyme utilized,
specifically, the Jack Bean Urease enzyme, is known to form by six subunits arranged in an
octahedral manner32. It is estimated as have a cubic structure with equal dimensions (11.5 nm
side) sedentary on the substrate surface. The rate of the enzymatic reaction used in the previous
calculations was converted to an equivalent uniform flow of products that occurs from the
surface and the ammonium ion dispersal from the surface was converted to pH using equation
(5). Figure 2-5 depicts the resulting pH distribution in a plane perpendicular to the substrate. As
is made evident, the pH decreases as the distance from the enzyme surface increases.

Figure 2-5 [27,38]: Analytically calculated pH created by individual urease molecules.

Analytically calculated pH created by individual urease molecules.
In order to analytically calculate the pH based on individual molecules, certain

arison with
the analytically calculated pH gradient, a more realistic nu
approximations had to be made. Firstly, the approximation had to be made that the enzyme
urease is the source of products (ammonia and carbamic acid), on a flat surface. The products of

of the diffusion pattern was carried out with a Finite Element Method (COMS
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igure 2 in	
   the main text. The Jack Bean Urease enzyme, which is formed by

the enzymatic reaction, produced at a certain rate of v molecules per second diffuse away from
the urease molecule according to the Fick’s law of diffusion from an area of high concentration
to an area
of lowcalculation
concentration
ofgradient
the gas in question. It can be said that the movement of
Theoretical
of the pH
ammonia
and carbamic acid occurs in the shape of a semi-sphere encompassing the enzyme and
We approximate the enzyme as an ideal point source of products on a flat surface. The products
the enzymatic
reaction,
at which
a rate ofcan
v molecules
diffuse
that thisofstream
of products
isproduced
uniform,
allows per
forsecond,
equation
(1).away from the
urease molecule according to the Fick’s law of diffusion. The flow of products are distributed
uniformly over a semispherical area around the enzyme, leading to the equation

(1)27

(1)

where D is the diffusion coefficient of the products, c is their concentration, and r is the distance
to the enzyme. The concentration of products is calculated by integration of equation (1) with the
condition of zero concentration at the bulk of solution:

D is the diffusion coefficient of the products, c is the concentration of products, and r is the
(2)

distance to the enzyme. The concentration of products is calculated by the integration of equation
The primary products of the enzymatic reaction are carbamic acid and ammonia. Although the

(1). It is assumed that there is zero concentration found in the bulk of solution.

acidity constant values for the ionizable groups of carbamic acid are not available, it is
reasonable to assume that it stays in its zwiterionic form at near-neutral pH, similar to other

	
  

aminoacids such as glycine. Carbamic acid is an unstable compound that decomposes to form

	
  

ammonia and carbon dioxide molecules. However, with a rate constant of 0.22 s-1 [1], and hence

(2)27

a halve-live of 3 s, the decomposition of carbamic acid takes place when these molecules have

	
  

diffused far away
	
   from the enzyme. Therefore its effect on pH can be neglected. Ammonia, with
a pKa of 9.75, will instantly protonate and diffuse mainly as ammonium ion. Only a small
fraction of ammonia (<1%) will remain non-protonated, so little error will be introduced by

The primary products of the enzymatic reaction, as mentioned before, are carbamic acid and
ammonia. Although the acidity constant values for the ionizable groups of carbamic
acid are not
S1
available, it is reasonable to assume that it remains in its zwitter-ionic form at near-neutral pH,
similar to other amino acids such as glycine. Carbamic acid not a stable compound and,
25	
  
	
  

	
  

therefore, decomposes to form the products of the hydrolysis reaction. However, with a rate
constant of 0.22 s-1 [1], and hence a half-live of 3 seconds, the decomposition of carbamic acid
takes place when they diffuse far away from the enzyme. It is safe to make the assumption,
therefore, that it has no impact on the pH of the surroundings immediately around the enzyme.
The pKa of ammonia is known to be 9.75, which will cause immediate protonation and diffusion,
where it exists in ammonium ion (NH4+) form. Only a small fraction of ammonia (<1%) will
remain un-protonated; which allows the assumption to be made that complete protonation takes
place. Looking at the ion products of water and the electroneutrality condition:

assuming complete protonation. Taking into account the ion product of water and the condition
[H+][OH-] = 10-14
(3)27
of electroneutrality
[NH4+] + [H+] = [OH-]
(4)27

[H+][OH-] = 10-14

(3)

[NH4+] + [H+] = [OH-]

(4)
A relationship between the pH and the ammonium ion concentration is obtained, where:
a relation between the pH and the ammonium ion concentration is obtained
(5)
(5)27

The rate of reaction has been calculated with the Michaelis-Menten equation for a single urease
molecule
The rate of reaction has been calculated with the Michaelis-Menten equation for a single urease
(6)
molecule:

where [S] is the substrate concentration and Kcat and Km are the catalytic constant and Michaelis
constant, respectively. Values of 35220 s-1 (hexameric form with a 5870 s-1 per catalytic subunit)
[2]. In order to maintain the
	
  
26	
   and 2.9 mM have been used for Kcat and Km, respectively
	
  
electroneutrality,
diffusion of ammonium ions and OH- takes place collectively, and the

associated diffusion coefficient has been calculated as the harmonic mean of the individual

The rate of reaction has been calculated with the Michaelis-Menten equation for a single urease
molecule

(6)

(6)27

where [S] is the substrate concentration and Kcat and Km are the catalytic constant and Michaelis
constant,
Values of 35220
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calculated as the harmonic mean of the individual diffusion coefficients, giving a value of
2.85x10-9 cm2 s-1 33.
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2.4.2a. Atomic Force Microscopy (AFM)

Once the enzyme-substrate, urea is added, the enzyme urease immobilized on the
Si substrate leads to the production of ammonia at the enzyme/solution interface.

This

increasing pH value allows for the essential hydroxyl-functionalized (-OH) groups to be present.
The inherent affinity for metal ions (from the Zn2+ precursors) by urease combined with the
optimum pH conditions, allows for the growth of oxide encompassing the enzyme, which serves
as the nucleation point. It is from this pH gradient that results in the formation of low-reactivity
intermediates that ultimately lead to the formation of the amorphous material on urease29,30.

a)	
  

	
   c)

b)	
  

	
   d)
c)

d)
	
  

Figure 2-6 a-d[27]: ZnO nano-patterning by the newly developed BCN with the tip velocity
of 100 nms-1 and the tip force of approximately 100 nN: a) AFM image of the amorphous ZnO
ink synthesized on the silicon substrate, scale bar is 1 micron; b) AFM image after
nanopatterning the amorphous ink as a line, scale bar is 1 micron; c) section analysis of
amorphous ZnO/Zn(OH)x inks in (a); d) section analysis of crystalline ZnO line in (b).
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Following this step, the AFM tip is dipped into the amorphous ZnO ink and the oxide
semiconductor nanopatterns are subsequently written in contact mode of AFM. Figure 2-6(a)
shows an atomic force microscopy (AFM) image of an inkwell of amorphous ZnO synthesized
on the Si surface and Figure 2-6(b) shows the subsequent contact mode writing of micrometerlength nanowires using the inkwell of amorphous ZnO.
Because of the notion that no photoluminescence or contrast was detected when the
substrate was imaged by either fluorescence microscopy or polarized light microscopy (See next
results and discussion section), this indicated that the material was still in the amorphous phase,
as shown in Figure 2-6a. After the AFM tip was positioned at the center of the coated urease to
load the amorphous ZnO, the ink was dragged by the AFM tip with a tip velocity of 100 nm s-1
and a tip force of approximately 100 nN to yield ZnO lines as shown in Figure 2-6b.
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2.4.2b. Atomic Force Microscopy (AFM)

Despite the success of this newly developed type of nano-lithography that allows for both
patterning and crystallization, as shown above in Figure 2-6, further experiments were discussed
and planned to downscale this patterning technique to produce nanometer range patterns (less
than 100 nm) so that this technique and yielding products could potentially produce results for
high-tech applications. It should be noted that, as shown in Figure 2-6b, heterogeneous
crystalline domains on individual ZnO lines were observed as a result of the different
directionality of crystal nucleation.
As a method to decrease the dimensions of the nanowires and fabricate more
homogeneous structures along the line during the writing process, it was thought that by simply
increasing the velocity of the AFM tip during the writing process to 500nm s-1, that this would be
the correct route to follow to yield the desired homogeneous nanowires with smaller and more
applicable dimensions. The speed with which the tip moves influences how high and
homogeneous the written lines end of being, as shown in the developed DPN nano-patterning
technique by Mirkin et al34. In this innovative development, the quick and constant speed of the
AFM tip being used results in the deposition of a smaller amount of “ink” on the Si surface.
Because the faster speed yields a smaller amount of ink deposition, it makes sense that the
dehydration process occurs at a quicker rate to result in homogeneous nanometer size ZnO
patterns that exhibit crystal growth in the same direction (isotropic). As shown in Figure 2-7a,
these occurrences are observed. From the height profile corresponding to the AFM image, the
height of these nanometer patterned ZnO lines are approximately 12 nm.

In order for this

method to have profound use in specific areas of industry and thus more impact, it should have
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the ability to produce more than just one nanowire of crystalline ZnO. As should in Figure 2-7b,
this ability was tested. As is evident, BCN can yield multiple ZnO
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   In summary, biomimetic crystallization	
   nanolithography
Allen, K. Fiel
	
  
(BCN),
a new nanofabrication methodology, was introduced
D. E. Morse,
to generate crystalline oxide semiconductor nanopatterns
[2] D. Kisailus, Q

excelled precision and capability that the BCN method consumes for the yielding of nanometersized nanowires. Simply by increasing the speed with which the AFM tip “inked” the Si surface
yielded more homogeneous nanowires, which shows the tremendous potential this nanopatterning technique has. The generation of crystalline nanoscale patterns is achievable by
carefully tuning the parameters and experimental design.
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light

[27,38]

: Optical images of amorphous ZnO inkwells; a) DIC light; b) polarized

. Optical images of amorphous ZnO inkwells; a) DIC light; b) polarized ligh
Figure 2-8a shows an optical image of the amorphous inkwells after the addition of the
Zn precursor. In this image, all of the inkwells are separated by distances on the microscale.
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This is indicative that the surface coverage of urease is low enough so that the production of
ammonia by one enzyme does not influence the production of ammonia on another enzyme.
Moreover, when the same area was imaged with polarized light, the ZnO inkwells were not
observed as is shown in Figure 2-8b. This evidence further supports the previously calculated
pH values in Figure 2-5 and Figure 2-4 and the hypothesis that the ink deposited on the Si
substrate is amorphous and is not crystallized until it is patterned with the AFM tip, which results
in
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2.4.4. Fluorescence Microscopy

The process by which the ZnO changes from amorphous to crystalline had to be
rationalized.

It has been shown by Aizenberg et al. that the movement of wedged water

molecules in the amorphous state could allow for quick crystallization to occur when the
amorphous ink is patterned with the tip of an AFM35. As seen in Figure 2-6b, the resulting
crystalline ZnO nanowire’s surface area is clearly of a higher magnitude than that seen in the
amorphous ink before patterning, as shown in Figure 2-6a. Due to this concept, as well as to the
notion that there is a generation of heat that is a direct result of the friction between the AFM tip
and the Si surface, the amorphous ink (ZnO/Zn(OH)x ) can oust the wedged solvent molecules.

	
  

	
  
Figure 2-927: Fluorescence image showing the blue emission of the resulting ZnO nanowire
from Figure 2-6b
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This eradication of water molecules, which is the previously mentioned dehydration
factor, can ultimately be held responsible for the transition between amorphous ZnO and
crystalline ZnO. The crystallinity of the resulting nanowires were confirmed using fluorescence
microscopy.

It is well known that crystalline ZnO has a characteristic blue fluorescence

emission at 547 nm36.

As shown in Figure 2-9, the AFM image of the resulting nanowire in

Figure 2-6b did, indeed, emit the characteristic blue emission. This support proves that it is the
writing process itself that is responsible for the crystallization of amorphous ZnO ink.
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2.5 Experimental Section
2.5.1 Synthesis of Amorphous ZnO Ink

In order to synthesize the amorphous ZnO ink, urease from Jack Beans was physisorbed
on 1 cm2 diced silicon wafers with a 350 nm layer of thermally grown silicon oxide by
incubating them with a solution of the enzyme (0.1 mg mL-1 ) in phosphate-buffered saline
(0.01m phosphate buffer, 0.0027 m KCl, 0.137 m NaCl ; pH 7.4 tablets, Sigma) for 1 hour. The
urease-modified substrates were then washed with deionized water, immersed in 100 mL of
NaNO3 (0.1m), and then urea (10mm) was added to create a suitable pH gradient for the
preparation of amorphous ink. Urease was allowed to produce NH3 around the enzyme for 30
seconds at which point the Zn-precursor, Zn(NO3)2·(H20)6 (0.1 mm) was added with mixing for
1 h to synthesize amorphous ZnO inks on the surface of the silicon substrate. Subsequently, the
substrates were washed with water and dried with streaming nitrogen for the following BCN
step.
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2.5.2 Biomimetic crystallization nanolithography and AFM analysis

After the amorphous inks were prepared on Si substrates, they were patterned by a standalone MFP-3D atomic force microscope (Asylum Research, Santa Barbara, CA). The position
and length of these lines was defined by the MicroAngeloTM software. BCN was performed in
contact mode by applying a tip force of approximately 100 nN and maximum tip velocities of
100 nm s-1 or 500 nm s-1. Ultrasharp silicon tips (MikroMasch) with a typical probe tip radius of
10 nm and a resonant frequency around 325 kHz were used for nanopatterning and imaging. For
each tip, the spring constant was determined by the thermal noise method.[26] All topological
images were taken in the tapping mode of AFM and treated with the WSxM software to enhance
the contrast. The average height values were obtained by averaging the section analyses of more
than eight lines. The variability in the measured dimensions was expressed as the standard
deviation.
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PART 2

ABSTRACT

DIRECT ENZYME PATTERNING WITH MICRO-CONTACT PRINTING & GROWTH OF
ZnO NANOPARTICLES ON THE CATALYTIC TEMPLATES AT ROOM TEMPERATURE

	
  
	
  
A micro-contact printing (µCP) process was developed and utilized as a means to directly
pattern enzymes in a single step without the loss of enzyme activity after printing. By modifying
the substrate to display aldehyde groups, the direct stamping of urease enables the simultaneous
patterning and covalent cross-linking of urease under the reducing agent NaCNBH4, which does
not degrade the enzyme activity. Because the enzyme was not treated by the cross-linker prior to
the sampling but rather pre-assembled on the surface of the substrate, only the contact areas of
the PDMS stamp reacted with the cross-linker on the substrate, minimizing the poisoning of the
enzymatic sites. The exposed urease particles on the substrate, free from the cross-linker, were
still catalytically active and utilized to grow crystalline ZnO nanoparticles on the enzyme
patterns in ambient conditions and in aqueous solution.
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CHAPTER 3

DIRECT ENZYME STAMPING FOR OXIDE SEMICONDUCTOR MATERIALS VIA
MICROCONTACT PRINTING

3.1 Introduction

Recently, the immobilization of enzymes on various surfaces has been investigated
extensively due to the numerous applications in the biosensors industry. Enzyme immobilization
is of critical importance since they can be detected through electrochemical or photonic signals
and can even be utilized in implantable biosensors1-3. Recently, there has also been much
research done regarding the surface attachment of catalytic enzymes as a means to grow various
inorganic materials on the surfaces of device building blocks such as nanowires and
nanoparticles for the development of novel materials with complex nanostructures4-5.
As a means to synthesize biosensors for highly-functional multiplexed applications
there is a need for the nano-patterning of enzymes, as evidenced by the recent interest expressed
in this field6. In order for implementation in devices, it has also been reported that through a
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nanolithography patterning technique, enzymes can serve as effective bio-templates for
nanoscale metal/semiconductor patterns for electrical circuits, since these enzyme-patterns
catalytically induce biomimetic biomineralization processes7.
Although the patterning of enzymes can be advantageous as mentioned above, the
main setback of doing so remains in the maintenance of enzyme activity once the enzyme is
transferred to the surface8. In order to take full advantage of the many positive attributes of
enzymes, it would be of great interest to overcome these shortcomings by improving the
enzymatic activity after patterning, so that their full potential is taken advantage of and applied to
a wide array of applications.
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3.2 Interest in the Immobilization of Enzymes on Glass for Biosensors

With respect to the extensive research being done to develop biosensors, especially as
a means to optimize efficiency, ease, and cost-effectiveness it is no wonder the use of enzymes
has been of high interest in industry, medicine, and biotechnology. Biosensors are composed of
two operational mechanisms involving both a detector of sorts, as well as an immobilized
biocatalyst portion17. Enzymes are known as excellent biocatalysts, mainly due to their ability
to increase the rate that a chemical takes place, while avoiding any effect on themselves.
Furthermore, they also have the ability to increase the reaction rate without changing the existing
product and reactant equilibrium20.
The immobilization of enzymes has been accomplished through the use of a variety of
substrates that end of surpassing their counterparts in solution in terms of their ability to be
recycled and used again. For example, according to a patent that uses penicillin G acylase
mutants, it was found that enzymes immobilized on a substrate were over 300,000 times more
stable as opposed to enzymes that were in solution, which shows potential for recycling of the
enzyme19. For a high-impact biosensor, it is the cheapest option to immobilize on a glass
substrate18.

Despite the cost-effectiveness of utilizing glass substrates for enzyme

immobilization, it has proven to be difficult in retaining activity of the enzyme once it has been
immobilized on a glass substrate21.
In order for enzymes to make an impact in terms of efficient biosensors, there needs to
be a way to immobilize and/or pattern them into specific arrays on glass substrates while
maintaining
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3.3 Nano-patterning of Catalytically Active Enzyme

There are several ways to pattern proteins9, cells10, and other bio-molecules onto
various substrates, as previously mentioned, which could possibly be applied to patterning of
enzymes. As an alternate to photolithography, Whitesides and coworkers introduced a novel
method known as microcontact printing (µCP) in 1993, where self-assembled monolayers of
alkanethiols were patterned onto gold substrates 11-12.
One of the most frequently used methods for immobilizing enzymes onto various
substrates is microcontact printing (µCP)13. This technique offers a way to control the patterning
onto the substrate efficiently and cheaply. The main characteristic of this top-down method is
the use of polydimethylsiloxane (PDMS), an elastomer, to form a patterned stamp, which can be
“inked” with a particular solution and pressed against a number of different substrates. The
biomolecule that is used as the ink is transferred to the substrate in regions where the PDMS and
substrate make conformal contact14. In order to effectively bind the specified enzyme or
biomolecule, the surface modification of the receiving substrate must be modified as to ensure
transfer of biomolecule between stamp and substrate. In understanding and taking note of these
necessary modification steps required, the fabrication of micro-scale level patterns can be
achieved by this soft-lithography method15.
Despite the fact that µCP is an emerging methodology to pattern enzymes on
substrates, since the patterning can be achieved at room temperature as well as in aqueous
solutions, the most significant setback that is necessary to overcome involves maintaining
enzyme
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3.4 Applications

As shown, enzymes immobilized on a substrate can act as a tool utilized for the
delivering of drugs22, the identification of tumors22, a means of purification23, as well as
potentially powerful biocatalysts18. Going a step further, the ability to maintain the activity of an
immobilized enzyme on a glass substrate would prove to overcome some problematic attempts
of utilizing glass, despite the notion that achieving something of this caliber would greatly
impact the biosensor field. If there was a way to nano-pattern active enzymes on a glass surface
through a cost-effective, simple, and efficiently, this would be highly advantageous for
multiplexed and high-throughput detection through photonic or electrochemical signals1-3,6.
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CHAPTER 4

DIRECT ENZYME PATTERNING WITH MICROCONTACT PRINTING & THE GROWTH
OF ZnO NANOPARTICLES ON THE CATALYTIC TEMPLATE AT ROOM
TEMPERATURE

Kristina I. Fabijanic1, Raquel Perez-Castillejos2, and Hiroshi Matsui1. J. Mater. Chem., 2011,
21, 16877-16879.

4.1 INTRODUCTION

4.1.1. Enzyme Arrays for Biosensors

As previously mentioned, the soft-lithographic method, microcontact printing (µCP) can
be an amazing and useful tool to pattern enzymes in specifically spaced orientations for
multiplexed and high through-put sensors. In order to “successfully” pattern enzymes, the
biomolecules’ activity should be maintained even after it is transferred to the surface1.
Even though the enzyme patterning is performed at room temperature and in benign
conditions (room temperature and aqueous solvent), the µCP of enzymes has still been reported
to result in a degradation of their activities due to the conformational distortions and the
simultaneous poisoning of active enzyme sites through the patterning process2.

Typically,

enzymes are stamped on the surface through immobilization by physisorption or chemisorption
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methods3. It was observed, however, that the activities of these enzymes decreased over time due
to the lack of binding stability that exists through the use of these robust, but weak interactions46

. As a means to address the aforementioned problem, the binding stability can be increased by

conjugating various coupling agents to the enzymes thereby utilizing covalent interactions for the
immobilization of said enzymes onto the substrate. Although this idea seems to solve the issue of
poor interactions, it brings up another regarding chemical treatments7. The addition of the
coupling agents has detrimental effects on the enzymatic active sites, which results in the loss of
activity even though the enzymes may have been attached on the substrates successfully8.
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4.2 Production of Catalytically Active Enzyme Nano-arrays
4.2.1. Urease as Catalytically Active Enzyme

To overcome these shortcomings, we developed a new and simpler process of enzyme
patterning based on µCP that improves the enzymatic activity after printing. In this patterning
technique, the biomolecules of urease (from the Jack Bean Plant) are directly stamped onto glass
substrates using polydimethylsiloxane (PDMS) stamps16.
With this process, the enzyme urease become covalently immobilized to the
glutaraldehyde (GA) –covered substrate in one single step with minimal structural deformation
while, simultaneously enhancing the stability of the binding to the substrate. This extremely
simple immobilization process requires a smaller number of steps and chemicals than previous
processes utilized for enzyme patterning, which causes the active sites of enzymes to be more
protected throughout the fabrication process.
To demonstrate the high enzymatic activity after the stamping process, the catalytic
mineralization of ZnO was examined on the enzymes patterned by µCP. When we incubated
the glass substrates (patterned with the enzyme urease) in a solution of urea and Zn precursors,
the biomineralization of ZnO was observed on the urease patterns. This outcome demonstrates
that the enzymatic activity is maintained high since catalytic product of ammonia from urea
increases the local pH around urease and this catalytic generation of ammonia is responsible for
the
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ZnO

growth

at

room

	
  

temperature9.

4.2.2. Direct Micro-contact Printing (µCP) of Urease

Micro-contact printing (µCP) offers a robust way to pattern biomolecules onto the
substrate efficiently and economically by using poly-dimethylsiloxane (PDMS) stamps, which
can be ‘‘inked’’ with physiological solutions and pressed against a specified substrate 10,11. These
biomolecules that are used as inks can be transferred to the substrate in regions where the PDMS
and the substrate make conformal contact

12

. During this extremely simple and advantageous

process, biomolecules can be stamped into complex patterns, dependent on the design of PDMS
stamps.
Taking microcontact printing as the tool and our previously done procedure involving
the concept of biomineralization of urease and urea to produced oxide semiconductor material as
the method, the notion of creating oxide semiconductor patterns in a new way could prove to be
interesting for the development of an optoelectronic, and intergrated circuits, for example13. In
the past, semi-conducting zinc oxide has been synthesized using organic solvents and high
temperatures that are expensive to synthesize and release hazardous by-products. In this study,
we combine our previously done work and the method of microcontact printing to stamp the
enzyme urease directly onto a desired substrate. The necessary linking step was the APTES-GA
modification step utilized to activate the glass surface for enzyme immobilization14. Once the
urease was transferred from stamp to substrate, this smart nano-material was then utilized to
synthesis crystalline zinc oxide micropatterns cost-effectively, reducing hazardous by-products,
and in ambient conditions, namely room temperature and in aqueous solution.
In order to effectively stamp enzymes on surfaces with high stability and in a method that
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avoids denaturation, the enzymes need to be firmly immobilized on the substrate after the PDMS
stamp is removed from the substrate once conformal contact is made. Furthermore, coupling
agents that are being considered to aid the immobilization process need to be carefully selected
so that they do not poison the enzymatic active sites. In this design, both the surface modification
of the receiving substrate, as well as the coupling process have been considered to ensure a high
yield of enzyme transfer from the stamp to the substrate and a minimum interference in terms of
enzymatic activity.
In Figure 4-1(a-e), the stamping process is illustrated. Glass substrates were initially
treated with 3-aminopropyltriethoxysilane (APTES), allowing the silane groups to react with
hydroxyl groups of the glass substrate. After glass substrates were cleaned with ethanol and a
UVO cleaner for 10 min, these substrates were immersed into a solution of 2% 3-aminopropyltriethoxysilane (APTES) in ethanol for 30 min, allowing the silane groups to react with the
hydroxyl groups of the glass substrate (Figure 4-1a). Subsequently, the APTES-coated substrate
was immersed in 0.5% glutaraldehyde (GA) for 1 hour as a means to create aldehyde-terminated
groups on the surface, as illustrated in Figure 4-1b. These aldehyde groups will bind covalently
to the amino groups of urease. It is critical to immobilize the urease immediately after rinsing the
samples thoroughly with deionized water and drying them under nitrogen flow; if unreacted
residues of GA remained in the solution, they could poison the enzymatic active sites and induce
the loss of enzymatic activity. It is known that using a reducing agent such as sodium
cyanoborohydride (NaCNBH4), that does not affect the terminal aldehyde functional groups,
while effectively changing Schiff bases into secondary amine structures, provides the most
promising yields in terms of immobilization15.
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Figure 4-1(a-e)[16]: Process of direct patterning of enzyme urease by microcontact printing
(µCP): (a) the glass substrate is functionalized with APTES; (b) the cross-linker GA is conjugated to
amine groups of APTES; (c) urease on the PDMS stamp is transferred to the substrate by cross-linking
aldehyde and the amino groups; (d) lift-off of the PDMS stamp leaves covalently coupled urease on the
substrate and (e) catalytically active urease mineralizes ZnO 10nanoparticles at room temperature after
incubation with the precursors.

Finally, a drop of urease containing solution (100 µg mL

-1

) and the reducing agent

NaCNBH4 (3 µg mL -1) (v/v 1:1) were added onto the surface of the patterned side of the PDMS
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stamp for 1 hour, as shown in Figure 4-1c. It should be mentioned that the PDMS stamp was
transformed to be hydrophilic through UVO irradiation prior to the incubating it with an aqueous
urease solution. As shown in Figure 4-1d, in order to covalently conjugate the aldehyde groups
on the glass substrate with the amino groups of urease, the urease-inked stamp was brought into
contact with the substrate and withdrawn after a contact time of 30 seconds. The urease-stamped
substrate was washed with deionized water three times prior to microscopic viewing and
analysis.
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4.3 Results and Discussion
4.3.1. Atomic Force Microscopy

The stand-alone MFP-3D atomic force microscope (Asylum Research, Santa Barbara,
CA) was used for all AFM analysis for this project. Ultrasharp silicon tips (MikroMasch) with a
typical probe tip radius of 10 nm and a resonant frequency around 325 kHz were used for
imaging. All of the topological images were taken in the tapping mode of AFM and treated with
the WSxM software to enhance the contrast.
The direct micro-contact printing (µCP) of urease from the micro-island array is
shown in an AFM image in Figure 4-2a. The 10 µm x 10 µm square patterns of urease have an
average particle height of 10.85 nm ± 0.921 nm, and the size of the individual enzyme particle is
in the same scale17. It is important to note that this urease immobilization was done at conditions
of neutral pH, under which the enzyme activity is optimal.
At lower pH the positive charge of the amine groups of urease hinders the conjugation
of the enzyme with the aldehyde groups of the substrate, which leads to a low immobilization
yield of urease on the glass substrate. In this stamping process, it is also critical to use NaCNBH4
as a reducing agent because NaCNBH4 can effectively transfer primary to secondary amine
group of urease without affecting the terminal aldehyde functional groups of the substrate so that
the cross-linking of urease with the glass substrate, results in a high immobilization yield18.
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Figure 4-2(a&b)[16]: AFM images of patterned urease substrate and subsequent ZnO synthesis;
(a) AFM image in phase mode of the urease-patterned glass substrate; b) AFM image in phase
mode of the ZnO nanoparticle array grown on the urease-patterned glass substrate in Figure 41(a-e).

To test our simple, quick, and cost-effective approach as a means to generate
increased enzymatic activity as well as a confirmation that this method yields active enzymes,
oxide semiconductors can be grown on the catalytically active nano-array of urease
biomolecules. As previously published, this smart material can be used as the nano-reactor
responsible for the room-temperature growth of the semiconductor oxide, zinc oxide9. In using
urease, the local pH around the enzyme particle can be controlled, whereby ammonia is produced
by the hydrolysis of urea.
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Figure 4-3[9]: The Synthesis of the ZnO nanoshells around the nano-reactor urease as a template.
Step A: NH3, ammonia, is firstly brought about as a result of urea undergoing hydrolysis in the
presence of urease. This step finely tunes the pH around the catalytic template. Step B: after
addition of the Zn2+ precursor, the growth of ZnO nanoshells is catalyzed by the local pH value
at the enzyme/solution interface.

As a result, an oxide shell is expected to catalytically grow in an encompassing way
around the nano-reactor, urease, as shown in Figure 4-3 [20]. Urease also presents the advantage
of its high affinity for metal ions, which will result in the urease particle intercalating
semiconductor precursors very efficiently and growing ZnO as a shell around the enzyme nanoreactor9. As shown in (e) in Figure 4-1 c & d, after urea (10 mM) was added to the ureasestamped substrate in NaNO3 (0.1 M) for 30 s, Zn(NO3)3$6(H2O) (0.1 mM) 15 was mixed and
allowed to react overnight. The AFM image in Figure 4-2 b, which serve as nucleating points,
shows the micro-square array provided in Figure 4-2 a, the difference being one is urease and
one figure (b) is after the ZnO synthesis around the stamped urease although the height of islands
is increased to 15.25 nm+/- 2.00 nm. This increase indicates that ZnO nanoparticles are grown on
the urease patterns.
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4.3.2. Fluorescence

To confirm that crystalline ZnO nanoparticles were grown on the urease patterns,
fluorescence images of the substrates were taken. As shown in Figure 4-4, these arrays emit blue
light in agreement with the characteristic 487 nm emission of ZnO crystals. Some islands do not
show strong blue emission, which is believed to be the result of the imperfect crystallization of
ZnO. It should be noted that the neutral 25 pH of the ZnO growth solution is important to
maintain high activity of the enzyme since extremely low pH denatures urease and no blue
emission was observed in urease-stamped glass substrates incubated with precursors at pH 3
(data not shown).

	
  
Figure 4-4[16]: Fluorescence image of the ZnO nanoparticle array showing the characteristic blue
emission of crystalline ZnO.
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4.3.3. Annealing and Aluminum Doping of ZnO

As previously mentioned, the intensity of fluorescence emitted was not expected to be
high as a result of the low concentration of the Zn2+ precursor utilized. In order to obtain more
affirmative results, the annealing of the zinc oxide was done post-synthesis is order to intensify
the Fluorescent signal seen. The annealing was done for a short period of time, namely 30
minutes and at low temperatures, namely 60˚C. The sample was brought for analysis
immediately following the cooling step.

FIGURE 4-5[16]: Fluorescent image of ZnO after overnight incubation and annealing at 60˚C for
30 minutes. Patterns observed are 10 µm in size. Inset shows selected region of patterns with 10
µm wide patterns and a separation of 10 µm.
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As seen in Figure 4-5, there is a higher yield in terms of patterns that are seen, in
comparison to Figure 4-4. Some are higher in intensity, which are most likely the patterns
initially seen, prior to annealing, whereas the low intensity patterns are most likely now evident
as a result of the annealing process. One would anticipate the other “micro-islands” showing
themselves as the annealing time increases. It is important to note that the patterns shown seem
to be larger and than the scale bar indicates, as well as circular. However, if seems as though
there is a glow encompassing the square pattern which is located in the center of this glow. This
phenomena can be credited to the annealing amplifying the intensity to a higher degree, so as to
create this glow. As a result of this experiment, more intense amplifications of the patterns were
observed.

	
  
	
  

Figure 4-6 [16]: Fluorescent image of ZnO after overnight incubation and Al-doping. Pattern size
remains consistent of 10 mm.
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As an alternative to annealing, it is known that the Al-doping of ZnO can be done at
fairly low temperatures, namely 60˚C by using aluminum nitrate nonahydrate (Al(NO3)3 • 9H2O.
The results obtained from this experiment, as seen in Figure 4-6 from fluorescence, indicate
micro-patterns 10 µm in size.
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4.3.4. Colorimetric Activity Assay

In order to evaluate the impact of pre-assembled GA on substrates to the enzymatic
activity, the ammonia production from urea between the urease-assembled substrate and the
conventional urease substrate where the mixture of urease and GA was assembled on the APTES
substrate was compared. In the comparison, the concentration of ammonia is monitored by a
colorimetric activity assay with the pH-sensitive dye, bromocresol purple (BCP).

	
  

Figure 4-7 [16]: Comparison of enzymatic activity between the urease-assembled substrate (⏏)
and the conventional substrate where the mixture of urease and GA is assembled (n).

As shown in Figure 4-7, the substrate assembled with urease shows an increase in
absorbance due to the pH increase via ammonia production. This indicates that the urease on the
APTES substrate does not reduce its enzymatic activity, while the conventional substrate where
the mixture of urease and GA is assembled shows no ammonia generation due to the denaturing
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of the enzyme urease. From Figure 4-7, it is estimated that about 65% of the enzymes retain
activity on the urease-assembled substrate. This result indicates that the patterning method in
Figure 4-1 enables the patterning of enzymes without losing significant degree of enzymatic
activity.
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4.4 Experimental Section
4.4.1. Surface Modification of Glass Substrates

Glass substrates (Fisherfinest; 25x75x1mm ) were first sonicated in acetone for 10
minutes, followed by isopropanol, and finally, ethanol to clean the surface. The substrate was
then placed in a UVO cleaner for 10 minutes to ensure cleanliness. The substrate was then
immersed into a 2% 3-aminopropyltriethoxysilane (APTES) (ACROS Organics) in ethanol
solution for 30 minutes and immediately following, was sonicated in ethanol to remove any
unbound silane molecules. Subsequently, the sample was immersed in 0.5% glutaraldehyde
(GA) (Sigma-Aldrich) for 1 hour in order to create an aldehyde terminated group, useful for
protein absorption. Samples were rinsed thoroughly with ddH2O, dried under nitrogen flow and
immediately utilized for stamping.
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4.4.2. PDMS Stamp preparation and modification

A stamp for microcontact printing was made by pouring a 10:1 mixture of PDMS (DowCorning, SYLGARD silicon elastomer 184) and curing agent over a photolithographically
prepared master with 10 mm width and 10 mm gap patterns. After the mixture was degassed and
no trapped air bubbles remained, curing was performed in a 60°C oven overnight. Finally, the
stamp was peeled from the master and ready for use. The stamp was treated with UVO and
utilized immediately. The enzyme urease (100 µg/mL) was mixed with an equal volume of the
reducing agent NaCNBH4 (3 µg/mL). Roughly 100 mL of solution was spread out over the stamp
and left alone for 45 min – 60 minutes. The excess liquid was taken up through touching one
corner of a KimWipe to the solution. The stamp was brought into contact with the glass substrate
and withdrawn after a contact time of about 30 seconds. The stamped substrate was washed with
PBS and ddH2O.
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4.4.3. Room Temperature Synthesis of ZnO

Post-stamping, the sample was immersed into a 0.1M NaNO3. Urea (10mM) was added
to create a suitable pH gradient. Urease was allowed to produce NH3 around the enzyme for 30
sec, and then Zn(NO3)3 • 6(H2O) (0.1mM) was added and left overnight. Subsequently, the
substrates were washed with water and dried with streaming nitrogen for further analysis. The
MFP-3D atomic force microscope (Asylum Research, Santa Barbera, CA). Ultrasharp silicon
tips (MikroMasch) with a typical probe radius of 10 nm was used for imaging. All topological
images were taken in the tapping mode of the AFM and treated with the WSxM software to
enhance the contrast.
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4.4.4. Annealing and Al-doping of ZnO
	
  
Due to such a low concentration of zinc precursor utilized to prepare samples in which
the zinc oxide was synthesized at room temperature, annealing of the oxide material was done in
order to amplify the emission for fluorescence purposes. After overnight incubation of the glass
substrate in the reaction chamber, the substrate was rinsed numerous times with water, dried with
N2, and placed into a 80˚ C oven for 30 minutes. The sample was allowed to cool, and brought
for fluorescence analysis immediately upon cooling.
Furthermore, another method was attempted as to increase the intensity exhibited in
fluorescence studies. The Al-doping of the zinc oxide procedure was carried out as previously
published in conceivably lower temperatures and in production ways that are more suitable for
large-scale production[24]. Briefly, 0.03 M of zinc nitrate hexahydrate (Zn(NO3)3 • 6(H2O), 98%,
Aldrich) was dissolved in 80 mL of deionized water. Ammonium hydroxide was added to the
solution to set the pH at 10.3. Subsequently, 5mM aluminum nitrate nonahydrate (Al(NO3)3 •
9H2O, 99.99%, Aldrich) was dissolved in the zinc nitrate solution. The glass substrate with the
synthesized ZnO material was placed into this reaction beaker and allowed to proceed for 6
hours at 60˚C. Immediately following, the substrate was extensively rinsed with ddH2O , dryed
with N2, and brought for FL studies.
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4.5 Conclusions

Patterns of the semiconductor, zinc oxide have been grown in a micro-array type of
pattern on glass substrates by mCP methods, modification of the glass substrate with the
APTES/GA method, and through the transferring and subsequent immobilization of the enzyme
urease onto the substrate, which acts as the catalytic template in this synthesis. The doping and
annealing of ZnO was done so as to intensify the characteristic fluorescence observed in the
samples. This biomimetic growth, which can prove to be useful in optoelectronics, was
performed in such a way as to limit the use of high temperatures and harsh solvents so as to limit
cost and hazardous by-products.
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LARGE SCALE 3D SELF-ASSEMBLIES OF MULTIPLE NANOPARTICLE COMPONENTS
IN PEPTIDE NANOWIRE FRAMEWORKS & ANALYSIS OF THEIR STRUCTURES &
POTENTIAL FOR SOLAR CELL MATERIAL
by

KRISTINA IVANA FABIJANIC

Advisor: Professor Hiroshi Matsui

Recently, there has been a growing demand to have the ability of fabricating nanosized
structures that are 3D in orientation, produced in large quantities and yield uniform shapes and
sizes. Biomimetic assembly has been given attention in that it relies on the use of bio-inspired
materials that are characteristically organized from the macroscale all the way to the nanoscale.
Peptides are one of nature’s building blocks that have the ability to take an active role in self71	
  
	
  

	
  

assembly and that can further be integrated to consequently yield the self-organization of
structures with interesting properties in high quantities. In this study, first, micron-sized
assembly of streptavidin-functionalized Au nanoparticles and biotinylated collagen peptides into
cubic structures was demonstrated as assembled peptide frameworks incorporate nanoparticles in
the exact position of unit cell, and then other fluorescent molecules or nanoparticles with biotin
moieties were co-assembled to generate complex 3D nanoparticle assemblies. Energy transfer
(FRET) and excitonic lifetime change of between QDs (donors) and AuNPs (acceptors) in these
assemblies were investigated. As the interparticle distance was changed, the FRET efficiency
also changed, shown by emission lifetime measurements. The energy transfer efficiency was also
affected by the number of acceptor nanoparticles around the donor QDs. This type of robust
large-scale 3D material assembly technique with precise positioning could be beneficial for
future bottom-up device assembly such as solar cells, batteries, and metamaterials.

72	
  
	
  

	
  

CHAPTER 5

LARGE SCALE 3D SELF-ASSEMBLIES OF MULTIPLE NANOPARTICLE COMPONENTS
IN PEPTIDE NANOWIRE FRAMEWORKS & ANALYSIS OF THEIR STRUCTURES &
POTENTIAL FOR SOLAR CELL MATERIAL

5.1 Introduction

Biomaterials are a class of materials that are inherently highly-organized as we move
from the macroscale, to the microscale, all the way to the nanoscale. These materials have
enormous potential to organize themselves into some really interesting structures in mild
conditions, which allow for large-scale production and emergence of novel-engineered threedimensional (3D) structures, as seen in Figure 5-11-3.
Biomimetic assembly is the perfect marriage between traditional physical and biological
systems in which emerging materials and structures can be assembled starting from the
molecular level using their intrinsic recognition properties. It incorporates the use of biological
materials that are naturally occurring or whose structures can be genetically engineered, and
whose morphologies can be more precisely tuned to create novel hybrid structures. The use of
such materials is favorable due to their inherent efficiency, cost-effectiveness, and
environmentally friendly nature4-9.
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Figure 5-1 [1-3]: Showing classic cases of biomineralization in nature; (a) upper left: SEM of
abalone displaying aragonite platelets separate by organic film that forms into mother of pearl;
upper left: self-aligned magnetite NPs formed by magnetotactic bacterium are single-crystals;
bottom left: mouse enamel consisting of hydroxyapatite crystallites that assemble into woven
rods; bottom right: sponge spicule of Rossella has layered silica with optical and mechanical
properties

There has been considerable work done utilizing DNA bionanotechnology for the
synthesis of such macromolecular structures10-14. The potential with using DNA for large-scale
applications remains limited with regard to scale, size, yield and cost12. Peptides, another one of
nature’s wondrous building blocks characteristically carry the specificity, flexibility, and
robustness desired to synthesize and assemble elaborate nano-architectures with interesting and
functional properties. Such architectures have been constructed using numerous interactions and
pairings, including, but certainly not limited to: peptide-peptide interactions15, antibody-antibody
interactions16, oligonucleotide-oligonucleotide pairings16, and the streptavidin-biotin interaction9.
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In the nano-world, specifically when we pay attention to DNA, peptides, proteins, DNA
origami, viruses, quantum dots and nanoparticles, we see how said nanostructured material,
within the size range of 1-100 nanometers, are size tunable and have unique properties especially
in terms of new quantum mechanical effects due to their surface to volume ratio (Figure 5-2).

Figure 5-2: The quantum effect obtained from nano-sized materials and practicality of
macro-sized structures; By finding a bridge to link these two “worlds” together would yield
production of quantum solid.

On the other hand, in the macro-world, where these quantum mechanical effects do not
come into play, practicality does, in the sense that now, we are dealing with a larger and more
manageable size range where the bulk properties could prove to be advantageous. If there is a
way to link the quantum effect obtained at the nanoscale with the practicality and manageability
that the macro-world provides, one would be able to obtain a quantum solid.
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Current methods of producing quantum dot solar cells, such as e-beam lithography, as
previously mentioned can lead to misalignments, defects, and is not a very cost-effective
technique if the goal is to produce an alternate means of producing energy that can compete with
current methods in terms of cost as well as efficiency.
By turning to and examining nanostructured materials such as quantum dots and
nanowires, their particular dimensions yield to interesting properties. Because they are in the size
range of 1-100 nanometers (nm), their properties are size tunable and unique simply by changing
their size or environmental conditions. These materials have the potential to contribute to our
future energy needs and have the potential to result in highly efficient solar cells and low cost.
Rather than etching nano-width lines on bulk semiconductors, through an
expensive and less-efficient top-down approach, it would be beneficial to begin on the nanoscale
and build upward from there.

The ability to use nano-sized quantum dots and/or metal

nanoparticles and combine these intrinsically interesting materials with a flexible material, such
as a protein that is also on the nanoscale could, allow for the self-organization of the system to
yield interesting 3D structures with photovoltaic material.
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5.2 Two-Dimensional to Three-Dimensional Assembly

In order to make promising and successful progression towards the bridging of the nanoworld with the macro-world and obtaining a quantum solid, there needs to be a way to
manipulate nanostructured materials and assemble them into desired three-dimensional (3D)
structures so that their unique photochemical properties can be taken full advantage of – there
needs to exist a certain flexibility and ability of the nano-materials being used so that they could
arrange themselves into different conformation, similar to that of DNA.

Figure 5-3 [17]: Formation of 3D DNA Tetrahedrons; (a) M13 single stranded scaffold DNA
consisting of 7,429 base pairs (b) & (c) The illustration in (a) is “stretched” to show the four
edges of the tetrahedron. The base pairs are held together by 248 short single stranded DNA
oligos (d) Formation of tetrahedron container
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For example, Yan et al., have successfully designed DNA Tetrahedrons, a type of DNA
origami17. In the case of the tetrahedrons, the M13 single stranded scaffold DNA contains 7,429
base pairs. These base pairs are held together by 248 short single stranded DNA oligonucleotides
and eventually lead to the formation of the tetrahedron container seen in Figure 5-3.
Similarly, Anderson et al., efficaciously designed 3D DNA boxes with controllable lids.
This phenomenal development used 6 DNA origami sheets that are folded along the circular
single stranded DNA genome of the M13 bacteriophage18. These six interconnected sheets are
then arranged to form a 3D box with controllable lid, as seen in Figure 5-4.

Figure 5-4 [18]: 3D DNA boxes with lids; 6 DNA origami sheets are folded along DNA genome
of M13 bacteriophage. Six interconnected sheets form the 3D box

Despite these amazing and notable discoveries, their still exists a fundamental problem
with DNA bionanotechnology in terms of macroscale practicality. The methods to develop
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highly ordered macroscopic materials from nano-materials remains limited. For practical
applications, the production, scale, size and yield of the assembled materials still needs a way to
be amplified for real-world applications.
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5.3 Using Proteins Found in Nature as an Inspiration

As previously mentioned, the main issue with DNA bionanotechnology is the
problematic lack of macroscale practicality. Perhaps, by turning to proteins and their interesting
properties, these problems can begin to be addressed.
Elgeseer et al. reported in 2007 about the reinforcement of liposomes in nature, with
specific regard to the protective S-layer growth on the bacterial exterior, where the S-layers were
reported to have co-evolved with these diverse structures19. In terms of some interesting
properties that proteins have evolved through their development, in Figure 5-5a the hexagonal
surface lattice may be seen in bacteria and in Figure 5-5b, the illustration depicts how the coevolved S-layers with their hexagonal surface lattices actually work to stabilize the proteins.

Figure 5-5 (a&b) [19]: Protective S-layer growth on bacterial exterior; (a) Thermoanaerobacter
thermohydrosulfuricus showing a hexagonal (p6) surface lattice; (b) Stabilization of lipid
membranes with S-layer lattices3
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From the above illustrations, it is clear to see how, in turning to nature, some very useful
properties can be taken advantage of in terms of using proteins for the building blocks for largescale assembly and stabilization/reinforcement of cells19.
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5.4 Quantum Dots & Au Nanoparticles as FRET Donor & Acceptor

Focusing in on quantum dots it is apparent that their magnificent properties and
applications, such as labeling and tunneling, can be taken advantage of simply by fine tuning
their size and thus, having control on various parameters such as fluorescence. In terms of 3D
quantum dot solar cells, as seen in Figure 5-6, quantum dots can be used to form a super-lattice
through self-assembly that can be used for energy production20.

	
  	
  	
  

Figure 5-6 [20]: 3D Quantum Dot Solar Cell Superlattice; The abilities of quantum dot to form
superlattices and when placed in between electrodes and a p-layer/n-layer combination, can
convert photons to usable energy.
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Quantum dots have the abilities to increase the gap between the conductive band and
valence band in solar cells. In Figure 5-7 (a&b), this increased gap leads to the formation of
mini-bands, which are separated by a region of zero density of states. This allows for two
photons to be generated instead of one with only one electron-hole pair. When the electron- hole
recombines, the excess energy increases efficiency of converting photons into usable energy,
with enhanced coupling20.

Figure 5-7 (a&b) [20]: Internal Quantum Efficiency of quantum dot solar cells and the ability to
create excess and usable energy; (a) Illustration of internal quantum efficiency of quantum dot
solar cells with increasing number of layers within the lattic; (b) Increasing distance between the
valence band and the conduction band leads to the development of a mini-band, which leads to
the creation of two usable photons for every one electron-hold pair.

The ability to tune the band-gap means more wavelengths that hit the cells are in the
conductive range, which can then be converted to electricity. So, due to their small sizes, they
can confine excitations within their tiny volumes that may lead to excess energy being harvested
(rather than it being lost as heat), which would increase the efficiency of converting photons into
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usable energy with enhanced coupling. On the other hand, in the case of bulk semiconductors,
their band-gap is fixed and limited by the choice of material that one chooses.
Gold nanoparticles, on the other hand have been extensively studies since the middle
ages, where artists would utilize them as dyes in stained glass windows of cathedrals and
palaces. It is interesting to point out that 10 nanometer particles absorb green light and thus
appear red, where smaller ones would even fluoresce.
Aside from the unique and purposeful qualities that quantum dots possess, the one
distinguishing quality that will be taken advantage of in this study is the concept of Forster
Resonance Energy Transfer (FRET). FRET is the mechanism that takes place between a donor
molecule and an acceptor molecule. In order for this energy transfer to occur, there are certain
conditions that must be satisfied: (1) The inter-particle distance between donor and acceptor
must not supersede the 10 nm distance threshold; (2) The emission field of the donor must
overlap with the absorption field of the acceptor. When FRET occurs, the emission intensity of
the donor should increase, while the emission intensity of the acceptor should decrease.
Furthermore, time-resolved experiments, in which the lifetime of the multicomponent system is
quantified, should decrease (decay faster) upon the energy transfer occurring.
In the case of quantum dot-525 and 10 nm Au nanoparticles, this energy transfer is
expected to occur as the emission of quantum dot (QD)-525 and the absorption of Au
nanoparticles (AuNPs) satisfy condition (2) mentioned above. For condition (1), there needs to
be some monitoring due to the fact that both AuNPs, as well as QD525 are conjugated with
streptavidin (SA) moieties. Because they both are conjugated with SA, there should not be any
clear or precise interaction aside from any random interaction that may incur between the donor
molecule and acceptor molecule.
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The biotin-streptavidin interaction is one of the strongest non-covalent interactions, with
a dissociation constant of 1015 kJ/mol. Since both donor and acceptor contain streptavidin, it is
of great interest to pursue the introduction of a protein into this system to measure any energy
transfer that may take place due to the decrease of the chromophores’ inter-particle distance. If
this protein could have varying degrees of biotinylation, this may result in the formation of some
interesting 3D structures with energy transfer abilities, applicable for solar cell technology.
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5.5 Genetically Engineered Biotinylated 877 Protein as Template

The main component of this multicomponent system, a collagen-like peptide has been
modified from F877, which has been used previously as bio-molecular templates for the
formation of nanowires. As H. Matsui et al. reported, Au nanowires of specifically ordered
dimensions have been successfully produced in which the collagen-like triple helical 877 peptide
(no biotin accepting portion) was coated with a Au-mineralizing peptide, Ala-His-His-Ala-HisHis-Ala-Ala-Asp, known as HRE. In coating the peptide, it allowed for the reduction of the Au
precursor (trimethylphosphinegold chloride (AuPMe3Cl). As a result, a uniform crystalline Aucoating encapsulated the peptide to yield the production of Au nanowires21.
Furthermore, the biotinylated portion of this collagen-like peptide has been reported as
providing the foundation and backbone for the formation of 3D cubic structures with streptavidin
conjugated gold nanoparticles9. As previously described, the difference between F877 and
BAP877 is the insertion of a 15 amino acid sequence (the biotin accepting peptide residue) at the
N terminus of the peptide. Aside from the incorporation of the amino acid sequence, there are
other interesting characteristics of this peptide; namely, the existence of a 63 amino acid
sequence taken from type I collagen’s α1-chain, repeating Glycine-Proline-Proline (GPP) which
is thought to improve stability, a foldon at the C-terminus which serves as the nucleation point
for the formation of the triple helix, and a further inclusion of a Cysteine-Cysteine knot to ensure
the formation of the triple helix, as shown in Figure 5-8 9,22,23.
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Figure 5-8 [9]: Representation of the 100% Biotinylated Peptide. At the N-terminus are the three
biotin sites, which is a direct result of the biotinylation of the lysine residue of the biotin
accepting peptide in vivo. Following the BAP is the α1-chain of type I collagen, the repeating
GPP sequence, Cys-Cys knot, and foldon at the C-terminus.

Figure 5-9 [9] (a&b): High yield of 3D cubic structures upon the combination of B877 with SAAuNPs; (a) Concentrations and size ratio between nanowires and NPs gave variety of assembly
shapes but when they hit the sweet spot, they can be assembled into micron-sized, cube-shaped
crystals, in high yield, as shown through TEM; (b) Closer magnification showed the 3D
configuration of tilted cubic structures.
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It was previously reported that biotin moieties were fully displayed in the case of Figure
5-99 to yield 3D cubic structures. However, as a result of recent further investigation performed
by our group, it has been discovered that the biotins are NOT fully displayed on the peptide as
previously though and that the estimated biotinylation is closer to 33.3%. When we assembled
the 100% biotin displayed B877 with SA-AuNPs, it was found that the yield of assembly is
extremely low. Therefore, we hypothesize that this is due to the rigidity of the assembly where
the interaction should be strong enough to associate peptides, but not too strong so that the
assembled structures do not have the ability to lock into certain configurations. As Figure 5-10
shows, the number of biotin sites on the protein can be manipulated from 0%-100%
biotinylation. In using as weaker interaction, it could prove interesting in terms of 3D structures
that are formed in solution and/or dried state as well as in terms of energy transfer efficiency.

a.)

b.)

c.)

	
  

Figure 5-10(a-c): Varying percentage of biotin sites for more ordered crystal formation; (a) 0%33.3% biotinylation may be achieved by NOT using DNA containing biotin ligase (pBiRa) and
without extra biotin. The biotinylation occurs as a result of the small amount of biotin present in
one of the precursors for protein synthesis; (b) 66.7% biotinylation may occur without pBiRa
containing B877 DNA with the addition of extra biotin; (c) 100% biotinylation occurs as a result
of pBiRa containing B877 DNA with the extra addition of biotin in the protein synthesis process.
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The number of biotins on the B877 peptide is easily manipulated. For an average of both
zero to one biotins on the peptide, a DNA expression free of biotin ligase (the peptide that is
responsible for the biotinylation at the lysine residue) is used. Furthermore, as is discussed in the
experimental data, there is no extra biotin added during preparation and purification of the
peptide. For an average of peptide having between one and/or two biotin sites, one can either use
a DNA expressing biotin ligase and not add any extra biotin or use a biotin ligase free DNA in
which case more biotin is added. In the aforementioned cases, it is suffice for the biotin that is
contained in tryptophan to biotinylate the peptide in question. For 100% biotinlyation to occur
(three biotin sites), a DNA expressing biotin ligase must be used and extra biotin must be added
(More details regarding experimental protocol for biotinylation are described in pages 125-128) .
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5.6 Applications

In terms of some valuable applications of creating a bridge between the nanoworld and the macro-world to create a quantum solid, the amazing abilities of nano-sized
materials are taken advantage of as is the practicality of self-assembling the nano-sized materials
on the bulk scale. If there was a way to assemble biomolecules into 3D structures, there are a
numerous number of possibilities that arise, specifically the ability to create 3D quantum dot
solar cells, the main inspirational application.
Despite the many advances that have been made, the current techniques that are
currently used leads to defects, misalignments, and is a far too expensive technique. The global
photovoltaic market looks set to ride out the economic downturn with a predicted growth hitting
$7.5 billion by 20154. They will only succeed in outshining existing methods by being able to
compete in cost and performance, which requires halving the price of current solar cells.
Through merging together the intrinsically amazing properties of nano-sized
materials with proteins being able to act as building blocks, the self-assembly of these two
moieties to produce structures at the macroscale could be an immensely advantageous discovery
for the development of cost-effective and efficient solar cells.
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5.7 Results & Discussion

	
  

5.7.1 Time-Resolved Fluorescence & Steady State Approximation of FITC dye and
Streptavidin Conjugated Au Nanoparticles

The genetically engineered B877 peptide was combined with Streptavidin Au
Nanoparticles (SA-AuNPs) and Fluoroisothiocyanate (FITC) initially, to confirm whether or

Steady-state fluorescence

Time-resolved fluorescence

Figure 5-11: (left to right) Steady-state fluorescence and Time-resolved fluorescence of SAAuNP/FITC/B877; (a) Steady-state fluorescence of multicomponent system; (b) Time-resolved
fluorescence of multicomponent system showing lifetime of Plain FITC (green-3.60 ns),
FITC+SA-AuNP (red-2.80 ns), and FITC+SA-AuNP+B877 (black-2.80 ns)
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not any energy transfer could be observed and what effect our biotinylated peptide had on the
system. It was believed that the covalent Au-S bond would produce a change in energy would
yield a larger degree of energy transfer, as seen in Figure 5-11.
From Figure 5-11a, it is evident that the introduction of, initially SA-AuNPs, into the
system results in a decrease or quenching of FITC’s emission intensity. However, upon the
addition of B877 into the system, there is little to no further quenching of the system. In Figure
5-11b, the same trend is observed. Once the SA-AuNPs are incorporated into the system, the
decay becomes faster from an initial decay time of 3.60 ns to 2.80 ns, a difference of 0.80 ns.
However, as seen from steady-state fluorescence when B877 becomes incorporated into the
system, the decay remains the same.

Figure 5-12a: Hypotheses for organization of FITC dye molecules and SA-AuNPs; small
FITC dye molecule (absorber) and SA-AuNP (quencher) bind through the gold-sulfur bond.
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As shown through Figure 5-12a, the FITC and SA-AuNPs are, for the most part,
becoming covalently attached through the gold-sulfur (Au-S) bond, which is bringing them at a
distance such that FRET may occur. Once the protein is introduced to the system, however, there
is no apparent rearrangement or effect of the protein. This indicates that the FITC and SAAuNPs are already organized at their most optimum configurations through the gold-sulfur bond,
such that peptide is not needed for energy transfer to occur. This makes sense because the Au-S
bond is a covalent bond, while the biotin-streptavidin interaction, although very strong, is not.
Once the SA-AuNPs and FITC dye molecules are incubated in solution, prior to adding peptide,
they already organize themselves in an orientation for FRET to occur due to the Au-S covalent
bond. Once peptide is incorporated into the system, it does not allow for the self-organization to
occur, since they are in their most optimum distances, which is evidenced from Figure 5-11.
As a result, their needed to be some modification in our design such that our biotinylated
peptide could have an interesting impact on our system, which required a weaker to no
interaction between some donor and our SA-AuNPs.
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5.7.2 UV-Visible Absorbance of B877 (Biotinylated Peptide) and Streptavidin
Conjugated Au Nanoparticles

	
  

As a means to demonstrate that the inter-particle distance keeps changing on a kineticbasis, UV-Vis spectroscopy was performed 29.
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Figure 5-22 [29]: UV-Vis Spectroscopy & Finite-Element Based Electromagnetic Modeling of
B877 and SA-AuNP system. Over time (20 minutes to 2 hours), there is a red shift (blue curve
àred curveàgreen curve) indicating decreasing distance or aggregation between SA-AuNPs in
the presence of B877.

Through Figure 5-22 the kinetic-representation of the assembly process is illustrated.
After 20 minutes, the characteristic absorption of 10 nm SA-AuNPs is observed at ~ 525 nm,
which is the wavelength of mono-dispersed SA-AuNPs in solution. After the B877 peptide is
added to the solution containing mono-dispersed SA-AuNPs, the system is allowed to assemble
for 1 hour. As shown in Figure 5-22 above, there is a red shift to a higher wavelength (lower
energy) indicating that the particles are becoming closer in proximity to each other, with an
observed inter-particle distance of 20 nm (center-to-center). After 2 hours, there is a further redshift that is indicative of the b.c.c. structure previously observed9. Since one additional particle
at the center position makes inter-particle distance to be 14 nm, this shortening distance is the
origin of the spectral red-shift. The longer the assembly time is, the shorter the observed interparticle distance becomes. This notion means that the SA-AuNPs, in the presence of B877, are
not only brought together at closer distances as is indicated by the initial 1 hour red-shift, but that
the SA-AuNPs are re-arranging themselves into an ordered structure, as is indicated by the
further red-shift after 2 hour assembly time.
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5.7.3 Distance-Dependent Time-Resolved Fluorescence Study of Streptavidin
Conjugated Quantum Dots 525 and Streptavidin Conjugated Au Nanoparticles in
Presence & Absence of B877
	
  

As discussed in the previous section (Pages 105-106), there is an observable red-shift in
the SA-AuNPs and B877 system, which indicates a decrease in inter-particle distances of SAAuNPs with a longer assembling time. Therefore, lifetime studies with assembly time were
deemed to be able to provide additional insight into this system. In order to be able to conduct
lifetime studies, as previously mentioned, there must be a donor and acceptor within the system.
Although the experiments were initially conducted with the use of dye as the donor fluorophore,
the next set of experiments utilizes Streptavidin Conjugated Quantum Dots 525 (SA-QD525) as
the donor molecule. The organic fluorophore, FITC, like most dyes, has a very narrow
absorption spectrum and therefore a more narrow emission span24,25. Quantum dots, on the other
hand, are able to absorb light in a more broad range of excitation wavelengths, which results in
an emission peak that more sharp and distinct. Furthermore, quantum dots have a brighter
emission than traditional organic dyes due to the confinement of electron-hole pairs26. The effect
of photobleaching is also not an issue when utilizing quantum dots because they are made of
inorganic materials, such as Cadmium selenide or Zinc sulfide, or both, as is the case when using
an organic dye, such as FITC. This concept of resistivity to the effect of photobleaching gives
quantum dots a longer lifetime as compared to dye molecules27. The aforementioned positive
characteristics inherent in quantum dots, makes them more favorable for the following
experiments.
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The SA-QD525 (donor) and SA-AuNPs (acceptor) were initially combined at a 10:1

	
  

	
  
	
  

	
  

	
  

	
  

	
  

	
  

	
   	
   	
  
	
  

	
  

	
  

	
  

	
  

	
  
	
   	
  

	
  
	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  
	
  

	
  

	
  

	
   	
   	
   	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  
	
  
	
  

	
  

	
  

	
  
	
   	
  

	
  

	
  

	
  
	
   	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  
	
   	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

	
  

molar ratio to monitor any energy transfer from donor to acceptor, as shown in Figure 5-12b.

	
  

	
  

SA- QD525 (donor)
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Figure 5-12b: Illustration of SA-QD525 as the donor molecule (blue) and SAAuNPs as the acceptor molecule (orange).

The biotinylated peptide is added to the system at a 2:1 volume ratio, which results in ~1000
times the molecules of B877 as nanoparticles in solution. The assembly was allowed to occur
for both 25 minutes as well as 60 minutes. As shown in Figure 5-13, an apparent increase in
decay time is observed between the combination of SA-QD525 and SA-AuNP after addition of
peptide, as well as after 1 hour assembly time. This is indicative that there is energy transfer
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occurring without peptide, but is rapidly decreasing once peptide is added which tells us that the
space between QDs and AuNPs may not only decrease due to the streptavidin-biotin interaction
allowing for peptide to bring QDs and AuNPs closer on average, but that there are more
acceptors of energy for each donor, which would result in a faster decay.	
  

QD & Au NP
τ = 14.0 ns ± 0.2 ns

QD + Au NP + peptide (25 min. assembly)
τ = 4.70 ns ± 0.2 ns
QD + Au NP + peptide (60 min. assembly)
τ = 2.03 ns ± 0.2 ns

Figure 5-13: Time-Resolved Fluorescence of SA-QD525, SA-AuNP & Biotinylated Peptide
(B877); Illustrates the faster decay once the biotinylated peptide (B877) is added to the system.
Moreover, a faster decay time is observed over time, from 25 minutes to 60 minutes, which
indicatives reorganization takes place. Lifetime of SA-QD525 (not shown) is 14.00 ns; Lifetime
of SA-QD525 & SA-AuNP is 4.70 ns; Lifetime of SA-QD525 & SA-AuNP &B877 after 25
minutes is 2.40 ns; Lifetime of SA-QD525 & SA-AuNP &B877 after 60 minutes is 2.03 ns.

Furthermore, there is an apparent role of peptide within this system as seen in the dark
purple and light purple decay, the 25 minute incubation time and 60 minute incubation time,
respectively from 2.40 ns to 2.03 ns. At 25 minutes, the B877 is bringing the SA-AuNPs and
SA-QD525 within a closer average proximity to each other as is evident from the faster decay
98	
  
	
  

	
  

(from 4.70 ns to 2.03 ns). After 60 minutes, there is still rearrangement occurring as is apparent
by the even faster decay, which further rationalizes the distance-dependent role of B877.
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5.7.4 Unit Cell Ratio Dependent Time-Resolved Fluorescence Study of Streptavidin
Conjugated Quantum Dots 525 and Streptavidin Conjugated Au Nanoparticles in
the Presence & Absence of B877
	
  

Based on previously published work done with the self-assembly of B877 and SA-AuNPs
into 3D cubes, the structures observed were organized in body-centered cubic orientations
(b.c.c.)9. Keeping this thought in mind, the incorporation of quantum dots into this system could
prove to be interesting, not just in terms of distance between nanoparticle and nanoparticle in the
presence and absence of B877, but also in terms of the unit cell ratio, in the presence of B877.
Figure 5-14 shows a b.c.c. structure, which features a center atom and eight corner atoms for a
total of nine particles, that should occur only in the presence of the biotinylated peptide (B877),
acting as a bridge or connector in bringing the nanoparticles closer such that FRET can occur.
Therefore, in the absence of B877, there should not be as large a change in decay time when
comparing lifetime of neat SA-QD525 and SA-QD525 + SA-AuNP because, without peptide,
the nanoparticles should not have any ordered configuration. Once peptide is added to the
system, on the other hand, there should be a significant change when comparing SA-QD525 +
SA-AuNPs with and without B877, respectively.
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Figure 5-14: B.C.C structure: Features 1 center atom (red) with 8 corner atoms (green)
with black support coming from B877

Based on this concept, a hypothesis was developed by changing the “unit cell ratio”
between the SA-QD525 (donor) and SA-AuNP (acceptor) with and without peptide. In the case
of just donor and acceptor without peptide, 1:1, 1:0.75, 1:0.50, & 1:0.25 ratios were prepared
(QD:Au). These set of experiments are different from the previous set in that the assembly time
is fixed as a means to obtain constant unit cell structures and constant inter-particle distances.
Due to the varying QD:Au ratios, it is hypothesized that control of FRET dependence on the
ratio, is achievable
To really investigate the role of B877 in this multicomponent system as a means to bring
donor and acceptor at a distance that would result in a more efficient transfer of energy, the same
experiment was conducted as in the previous section, but now in the presence of B877. As
previously mentioned, in the presence of B877, the nanoparticles should arrange themselves in a
b.c.c. type of configuration9, which should be shown through a faster decay initially as compared
to nanoparticles without peptide.
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A b.c.c. structure has a coordination number of 8, based on the 8 surrounding atoms
around the central atom. There are also 2 particles per unit cell, which is calculated by taking
into consideration the number of atoms as well as the contribution from each “type of atom.” The
center atom (red) gives us 1 of the particles, while the remaining 8 surrounding atoms each give
a contribution of 1/8th, which is the other particle. Therefore, there are 2 particles per unit cell,
as previously mentioned.
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Figure 5-15: Coordination of Unit Cell with Varying Ratios of SA-QD525 and SA-AuNPs
in the presence of B877. (left to right) Neat QD, 1:0.25, 1:0.50, 1:0.75, and 1:1. Arrow is
pointing from slowest decay to fastest decay: Neat QD to 1:1 ratio with peptide, respectively.
Due to the proteins’ biotinylated nature and the streptavidin moieties on both the
quantum dots and Au nanoparticles, it is expected that the protein should be able to bind to both
the quantum dots and Au nanoparticles taking advantage of the biotin-streptavidin interaction.
Due to the aggregation tendency of B877 (which will be discussed in the next section), it should
result in an even more increase in decay time. As shown in Figures 5-15 and 5-16, the decay of
varying ratios in the presence of B877 becomes even faster than the previous system.

102	
  
	
  

	
  

0

1.60
Time (ns)

3.20

Figure 5-16: Time-Resolved Fluorescence study showing the increase in lifetime in the
presence of B877; Lifetime of 1:0.25 (QD:Au) + B877 is 2.42 ns; Lifetime of 1:0.5 (QD:Au) +
B877 is 2.20 ns; Lifetime of 1:0.75 + B877 is 2.10 ns; Lifetime of 1:1 (QD:Au) + B877 is 1.67
ns.

lifetime is 2.20 ns. For the 1:0.75 unit cell ratio (one SA-QD525 surrounded by six SAAuNPs
In the case of 1:0.25 unit cell ratio (one SA-QD525 surrounded by two SA-AuNPs and
six SA-QD525) in the presence of B877, the lifetime is 2.42 ns. For the 1:0.50 unit cell ratio (one
SA-QD525 surrounded by four SA-AuNPs and four SA-QD525) in the presence of B877, the
and two SA-QD525) in the presence of B877, the lifetime decreases to 2.10 ns. The 1:1 unit cell
ratio (one SA-QD525 surrounded by eight SA-AuNPs) in the presence of B877 has a lifetime of
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1.67 ns. As the number of SA-AuNPs increases, the decay time increases, as expected. Although
each increase is by 0.20 ns, 0.10 ns, and ~0.40 ns, respectively, it suggests that peptide is indeed
playing a role in bring donor and acceptor closer together resulting in a significant transfer of
energy, as seen in Figure 5-17 as compared to without peptide.
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Figure 5-17: Combined Lifetime of Varying Unit Cell Ratios (QD:Au) in both the absence
and presence of 33.3% Biotinylated peptide (B877); Top Left: Lifetime of 1:0.25 (QD:Au) =
19.90 ns ± 0.2 ns and lifetime of 1:0.25 (QD:Au) + B877 is 2.42 ns ± 0.2 ns; Top Right: Lifetime
of 1:0.50 (QD:Au) = 19.79 ns ± 0.2 ns and lifetime of 1:0.5 (QD:Au) + B877 is 2.20 ns ± 0.2 ns;
Bottom Left: Lifetime of 1:0.75 (QD:Au) = 19.04 ns ± 0.2 ns and lifetime of 1:0.75 + B877 is
2.10 ns ± 0.2 ns; Bottom Right: Lifetime of 1:1 (QD:Au) = 9.80 ns ± 0.2 ns and lifetime of 1:1
(QD:Au) + B877 is 1.67 ns ± 0.2 ns.
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The decay time increased (became faster) as the number of acceptor atoms per unit cell
increased. In the case of neat SA-QD525, the concentration of which is 1011 particles/mL, this
sample should have the slowest decay since there are no acceptor moieties in solution. As
expected, the lifetime is fairly long at 20.40 ns. At the 1:0.25 ratio (QD:Au), there is one SAQD525 for every 1/4th SA-AuNPs at some random distance, owing to the slight decrease in
lifetime to 19.90 ns. At the 1:0.50 ratio (QD:Au), there is one SA-QD525 for every ½ SAAuNPs exhibiting a lifetime of 19.79 ns. At the 1:0.75 ratio (QD:Au), there is one SA-QD525
for every 3/4th SA-AuNPs with a lifetime equal to 19.04 ns. Finally, the 1:1 ratio is the one SAQD525 for every one SA-AuNP, with the expectedly fastest lifetime of 9.80 ns. As expected, as
the number of acceptor moieties (SA-AuNPs) around the center SA-QD525 increases, the
lifetime becomes shorter.
The results above are consistent with the proposed hypothesis that as the “amount” that
each SA-AuNPs can accept energy from the quantum dot increases, the lifetime becomes faster.
This notion is indicative of the fact that donor and acceptor are in in somewhat close proximity
to each other such that some energy can transfer from donor (QD) to acceptor (Au) in a random
orientation. Although the change in lifetime is not huge, it will allow the role of peptide to be
exploited to a higher degree.
In the absence of peptide, the lifetime decreases to a minimum of ~9.80 ns, whereas in
the presence of peptide, the lifetime decreases to a minimum of 1.67 ns. Therefore, the presence
of B877 allows for the arrangement of nanoparticles to occur such that they are at optimum
distances from each other as evidenced by the rough 8 ns decrease with and without peptide.
The role of B877 in this system is to clearly bring the SA-AuNPs and SA-QD525 and a close
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enough distance such that the maximum amount of energy transfer can occur, demonstrating the
potential of this system to be applicable to the work being done involving 3D QD solar cells.
Therefore, from the results above, it is evident that B877 affects the lifetime for
all the ratios performed, namely 1:0.25, 1:0.50, 1:0.75, and 1:1 of QD:Au in such a way that the
lifetime becomes faster, and this, is necessary for the QD-Au distance to decrease and thus show
a faster lifetime.
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5.7.5 Synchrotron Small-Angle X-Ray Scattering (SAXS)
	
  

In performing Synchrotron Small-Angle X-Ray Scattering analysis, there is an ability to
measure what phenomenon is occurring at the liquid phase with particle accelerators. With this
powerful instrument, the flow cell is illuminated with high-intensity X-ray sources. The scattered
radiation is then measured with the detector and is useful to reveal information about protein
molecules and nanoparticles31. Therefore, synchrotron SAXS is an integral part of this analysis
to obtain real-time information about the SA-AuNPs, as well as the peptide components of this
system as compared to conventional SAXS. In conventional SAXS, the sample being analyzed
needs to be crystalline and the beam spot size is fairly large at a range between 3 and 50
microns32. The use of synchrotron SAXS allows for a small amount of liquid sample that does
not need to be crystalline, which is more favorable for biological macromolecules. The
following experiments were performed on the B877 and SA-AuNPs system only to get a better
understanding of what is occurring in this twofold system. In the first sample, 33.3% displayed
biotin B877 was analyzed. As previously mentioned (page 98), it was found after further
investigation that when the biotin display on the B877 was 33.3%, the assembly was found to be
of high yield as compared to low yield of assembly when 100% biotin displayed B877 was
studied.
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Figure 5-18[30]: Synchrotron SAXS spectrum of B877; Low q slope of -1.8 indicates the
existence of a mixture of both peptide sheets and peptide bundles, while the high q slope of -4
indicates a lattice packing in 3D orientation.
As shown in Figure 5-18, the intensity decreases with a slope (log scale) of -1.8, which
corresponds to a mixture that exists of both large peptide bundles as well as possible peptide
sheets. Had the slope had a value of -2, it would indicate that there exists either bundles or
sheets; the difference of 0.2 indicated that there is a mixture of peptide association that exists in
solution. At high q, we see the expected slope of -4, as we expect for a 3D aggregation, which
suggests a possible lattice packing is taking place. Therefore the two observed peaks are
indicating the existence of a mixture containing both peptide bundles, as well peptide sheets
arranging themselves in some type of lattice packing.
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This SAXS spectra provides interesting information regarding the self-assembly of just 033% biotinylated B877 in terms of aggregation. This is in conjunction with the lateral
association of peptide previously seen9. With this insight as to how peptide associates itself in
solution, it can provide information as to what occurs once nanoparticles are introduced. By
turning to concentration studies, it should show how peptide plays a role in bringing together
nanoparticles.

Shorter SA-Au interparticle distance
with increasing B877 concentration

AuNP+High [B877]
AuNP + Low [B877]
AuNP + Lowest [B877]

	
  

Figure 5-19 [30]: Synchrotron SAXS spectra of Varying B877 concentration & constant [SAAuNPs]; Red Curve is the highest concentration of B877 & constant [SA-AuNPs]; Blue Curve is
the second highest concentration of B877 & constant [SA-AuNPs]; Green Curve is the most
dilute concentration of B877 & constant [SA-AuNPs].
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Next, the concentration dependence of the system is investigated with both varying B877
concentration and varying SA-AuNPs concentration. Initially, the concentration of B877 is
varied in terms of concentration, while the SA-AuNPs concentration is kept constant. In Figure
5-19, as the B877 concentration is diluted (red curve à blue curve à green curve), the intensity
decreases and the low q slope becomes less steep. The red curve maintains the -1.8 slope,
indicating that the mixture of large peptide bundles/ peptide sheets still exists at high
concentration. As the concentration of peptide decreases, the slope is becoming less steep,
indicating that a smaller number of aggregations are observed. Finally, at the lowest
concentration (green curve), there is, on average, little to no formation of large peptide bundles/
peptide sheets, as can be seen by the disappearance of the low q peak. In terms of the high q
peaks observed with varying B877 concentration, information regarding SA-AuNPs may be
extracted. At high B877 concentration, there is a very intense peak observed at high q. This
peak becomes less and less prominent when peptide is diluted, which indicates that the particles’
inter-particle distance is increasing from the originally calculated 11 nm30. This provides insight
to the notion that as peptide is diluted there are a smaller number, on average, of peptide
bundles/peptide sheets in solution. As the number of peptide aggregates decrease, the interparticle distance between SA-AuNPs increase, as shown through the intensity and sharpness of
the SA-AuNPs peak ~ q = 0.5. Furthermore, through Figure 5-19, it is apparent that the
formation of large peptide bundles/ peptide sheets is inherent and dependent on concentration of
peptide, with the peptide showing less formation of large peptide bundles/ peptide sheets, as
concentration decreases. As previously mentioned, the Au peak is becoming less and less
prominent with decreasing concentration, which shows how the inter-particle distance between
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each Au nanoparticle is increasing due to smaller number of peptide aggregates (mixture of
bundles and sheets) in the system. Furthermore, the results above indicate that the SA-AuNPs
are NOT assembling into well-defined alignments in solution.

Therefore, once peptides

assemble the SA-AuNPs in high density encompassing the bundles/sheets in some conformation,
the SA-AuNPs and peptide aggregates seem to re-organize and form a b.c.c. type of arrangement

	
  

	
  

of the nanoparticle unit cell during the drying process.
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B877 + low [AuNP]
Neat [AuNP]

Neat B877

Figure 5-20 [30]: Synchrotron SAXS spectra for B877 and varying [SA-AuNP]; Blue curve at
highest intensity is B877 and high concentration SA-AuNPs; Red curve is B877 and low
concentration SA-AuNPs; Army green curve is neat SA-AuNPs; Neon green curve is neat B877.
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11 nm

In the case when 10 nm SA-AuNPs are added to the B877, the slope at low q (0.01) is
still observed as in the case of just peptide (with no SA-AuNPs). The low q slope still indicates
some mixture of bundles and sheets forming, whereas the slope at high q, shows the classic peak
for SA-AuNPs as shown in Figure 5-20. The blue curve, B877 and high [SA-AuNPs], shows
the low q peak of -1.8 as in Figure 5-18. The red curve, of second highest intensity is the B877
and low [SA-AuNPs] sample. As expected, the lower the concentration of SA-AuNPs, the lower
the intensity is at both low q and high q., which indicates two occurrences. At low q, the
intensity of the peak decreases which indicates that the number of peptide bundles/sheets is
decreasing. At high q, the SA-AuNPs peak is decreasing in intensity and broadening indicating
which shows that high SA-AuNPs concentration scattering dominates the high q peak such that
no useful information regarding the arrangement of nanoparticles in this sample may be
obtained. The third highest intensity peak (army green) is the sample containing neat SAAuNPs. Finally, the lowest intensity curve (neon green), shows identical peaks as in Figure 5-18
of neat B877. Comparing the curve for neat SA-AuNPs with the curves of samples containing
peptide, it can be said that the intensity increases due to the SA-AuNPs becoming closer together
(distance between nanoparticles is decreasing), which is consistent with the findings in Figure 519.
If the red curve is examined, it is evident that there are two “kinks” that are observed.
The first “kink” at a q value of 0.01 is indicative that there are existing aggregates and the
existence of a second “kink” (q = 0.02) provides information regarding not only the size of the
aggregation, but the # of particles per aggregation. From these two q values, it was estimated
that, on average, there are ten particles per 60 nm aggregation. Furthermore, the addition of SAAuNPs allows for a close-packed structure to occur in SOLUTION, with an average inter-
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particle distance of 11 nm. Each aggregation consists of ~10 SA-AuNPs per 60 nm size
aggregation30.
Lastly, the thermodynamic assembly of the B877 and SA-AuNPs in solution was
examined, as seen in Figure 5-21 gain insight as to what the most stable structure looks like.
When the solution containing both components was heated to ~38°C and then cooled back down
to room temperature (blue curve), there was a shifting out of the peak indicating that the particles
are getting closer together (~10 nm) upon annealing.

The annealing gives insight to the

thermodynamically favored structure, while a sample that is not annealed gives insight to the
kinetically driven structure, which keeps changing over time.

Figure 5-21 [30]: Synchrotron SAXS spectra showing effect of annealing on B877 & SAAuNPs system; Red curve: Non-annealed sample indicating kinetically driven structure with an
inter-particle distance of 11 nm; Blue curve: Annealed sample indicating thermodynamically
stable structure with an inter-particle distance of 10 nm
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The SAXS spectra analyzed above provides some awareness as to what is occurring in
solution with this ultra-sensitive system. The B877 itself can form self-assembling aggregates in
of itself. Remarkably, upon the addition of SA-AuNPs, there is an observed close-packing of
nanoparticles that occurs, which is evident by the 11 nm center-to-center distance. It is now
known that, in solution, there is an apparent aggregation that occurs to yield 60 nm sized
aggregates with roughly ten SA-AuNPs per aggregation. This finding is immense progress in
coming to an understanding of what takes place in the drying phase, as evidenced through the
annealed SAXS data previously mentioned. In solution, it is apparent that there is some random
aggregation that is occurring and, upon drying, allows for the SA-AuNPs and B877 to rearrange
itself into an ordered structure. The preferred thermodynamic structure can be reached in
solution, which is promising when trying to understand what is occurring during the drying state.
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5.8 Experimental Section

	
  

5.8.1. Amplification and Purification of B877

The bio-molecular template B877 was synthesized using F877 as a starting point with the
incorporation of the biotin accepting peptide at the N-terminus by utilizing PCR (PrimeSTAR
HS DNA Polymerase; Takara Bio Incorporated) and the plasmid pET32a-877 with the following
forward and reverse primers, respectively1:

F5’GGATCCGGTCTGAACGACATCTTTGAAGCGCAGAAAATTGAGTGGCACGAAGGT
CCTCCTGGACCACCTGGG-3’
R 5’-GGATCCGCCACAGCACGGACCTG-3’
The fusion protein obtained was then sub-cloned into the pCR4 blunt TOPO (Invitrogen,
Carlsbad, CA) plasmid and the sequence was verified by DNA sequencing (ABI PRISM 3100Avant Genetic Analyzer, Applied and Biosystems, Carlsbad, CA)9.
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Figure 5-239: Representation of the construct and modification from Biotin Accepting
Peptide 877 (BAP877) into Biotinylated 877 (B877). The addition of biotin ligase (pBirA)
allows for the 100% biotinylation of the peptide, which yields three biotin sites as is indicated by
the triangles attached to the the rectangular bars. pBiRa specifically biotinylates the lysine
residue of the BAP, which is represented in the 15 amino acid sequence by the letter K. Without
the addition of pBiRa, the number of biotin sites are sporadic, ranging between 0 and 1 (0% or
33.3% biotinylated B877)

The reconstructed DNA plasmids for both “good” B877 and “bad” B877 were
engineered, whereby the “good” plasmid contained biotin ligase (pBirA) and the “bad” plasmid
did not contain the biotin ligase. The two varying DNA (by either including or excluding biotin
ligase) were then transformed using chemically competent BL21-DE3 cells (OneShot BL21 Star
Chemically Competent E.coli, Life Technologies) by a prescribed method: 5 µL of each type of
DNA was added to the OneShot Vial. The vial was then placed on ice for 30 minutes, while a
water bath (42°C) was prepared as was 250 µL of SOC media. Following incubation on ice, the
vial was placed in the water bath at the aforementioned temperature for 30 seconds so as to
soften the cell wall for incorporation of DNA into the E.coli membrane. Immediately thereafter,
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the vial was placed back on ice for 2 minutes. At this point the BL21-DE3 E.coli cells have the
desired DNA incorporated into their membranes. The ice treatment acts as a means to stiffen the
membrane prior to plating. 250 µL of pre-warmed SOC media is then added to the vial and the
entire vial is placed on a shaker at 37°C for one hour. It is important to note that depending on
which DNA is utilized, there is a requirement to utilize specific antibiotics. For 100% B877, in
which biotin ligase (pBirA) is incorporated into the plasmid, both ampicillin (50 mg/mL) and
chloramphenicol (10mg/mL) is needed. For 0%-33.3% B877, ampicillin (50 mg/mL) is needed.
Plating is carried out on Agar plates containing 1.5% Agar, 100 mL LB Media, 10 µL of
ampicillin (50 mg/mL), 10 µL of chloramphenicol (10mg/mL) depending on desired percentage
of biotinylation. Each petri dish contains ~20 mL of the above recipe after autoclaving and left to
stiffen. For each B877, both 10 µL and 20 µL samples are plated and left overnight at 37°C.
The following day, one or two colonies are picked up, under sterile conditions, and placed in 60
mL of LB media with the appropriate antibiotic (60 µL of 50 mg/mL ampicillin for 0%-33.3%
biotinylated B877 or 60 µL of 50 mg/mL of ampicillin and 60 µL of 10 mg/mL chloramphenicol
for 100% B877) and left overnight. In the meantime, 6L of TPP media are prepared and
autoclaved. 6L TPP media consists of 120 grams Tryptone, 90 grams Yeast Extract, 48 grams
NaCl, 24 grams Na2HPO4, and 12 grams of KH2PO4 in 3L of water. The pH of the solution
should be adjusted to 7.5 using NaOH and distributed evenly to each 1L flask. 3L of water are
then evenly distributed to each 1L flask further diluting the solution. Furthermore, 80.0 grams of
Dextrose is added to 200 mL H2O. The aforementioned solutions are all autoclaved. Once
cooled, 25 mL of dextrose is added to each 1L flask as is the appropriate antibiotic in a 1 mL to 1
µL ratio.
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The following day, the inoculation consisting of 60 mL LB Media, appropriate antibiotic
and 1 colony of transformed BL21-DE3 E.coli with either B877 DNA, is added to each flask
under sterile conditions. Each 1 L flask is placed in the shaker at 37°C and 200 rpm until the
optical density (OD600) is ~0.5. At this mark, the cells are induced through the addition of
Isopropyl β-D-1-thiogalactopyranoside (IPTG) at a final concentration of 0.5 mM. The flasks are
then left in the shaker overnight at a reduced temperature of 25°C and a shaking speed of 200
rpm.
Following induction, the cells are harvested and the pellets are collected through
centrifugation at 4°C and 6300 rpm’s for 15 minutes and placed in falcon tubes. 25 mL of 1x
Wash Buffer, 250 mL of 100mM PMSF, 1 mL of 20 mg/mL Lysozyme, 20 mL of DNAse, & 20
mL MgSO4 are added to the pellets and re-suspended. Once thoroughly re-suspended, the
solution is transferred into a clean falcon tube and undergoes sonication. Sonication conditions
include a duty cycle of 50%, output of 3, and alternating 30 seconds on/ 1 minute off, which is
repeated 4 times to ensure complete breakage of the cell wall. The cell extract is transferred to a
new 50 mL falcon tube and centrifuged at 7800 rpms for 30 minutes at 4°C to separate the
supernatant containing the B877 from the pellet.
The supernatant can then be purified through use of a Ni-NTA agarose resin column
through the histidine tag (His-tag) of the protein and Ni interaction of the column as a means to
separate the protein of interest from the other proteins in the supernatant. ~4mL of resin is added
to the supernatant and placed on a shaker for 1 hour at 4°C. Subsequently, the supernatant is run
through the column. All liquid that comes out of the column is the non-binding protein, while the
B877 remains bound to the Ni-resin inside the column. Several washes are performed with 10
mM Imidazole and 50 mM Imidazole so as to ensure removal of all non-binding proteins.
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Finally, 100 mM Imidazole is used to release the protein from the Ni-resin column and is
collected as the elution. The elution is dialysized overnight in 1x Wash Buffer at 4°C. Following
dialysis, thrombin is added to the elution to cut the thioredoxin by means of thrombin cleavage.
The final protein is then collected through High-Performance Liquid Chromatography (RPHPLC, Beckman Coulter) with a C18 column (Vydac). The characteristic peak of B877 is
evident ~ 42 minute mark and is collected and lyophilized. The degree of purity is further
analyzed by running a SDS-Page (Commercial Mini-Cell, Invitrogen), where a band is seen ~20
kDa. As previously reported1, the triple helical peptide is a monodisperse nanowire with a length
of ~40 nm as has been confirmed by Circular dichroism spectrum and Transmission Electron
Microscopy (TEM), respectively.

1

2

3

4

5

6

Figure 5-24: SDS-Page as a means to confirm the presence of B877. Lane 1: Mark12TM
(Invitrogen) Unstained Standard excerpt showing ~36.5kDa, 31.0kDa, 21.5kDa, 14.4kDa, and
6kDa top to bottom ; Lane 2: PageRulerTM Plus Pre-stained Protein Ladder excerpt showing
(ThermoScientific) 35kDa, 25kDa, 15kDa, and 10kDa top to bottom; Lane 3: NonBinding
protein; Lane 4: Wash #1 with 10 mM Imidazole; Lane 5: Wash #2 with 50mM Imidazole; Lane
6: Elution Post-Thrombin and Dialysis
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5.8.2. Preparation of 10 nm Streptavidin Conjugated Gold Nanoparticles

	
  
10 nm Streptavidin Conjugated Gold (SA-Au) Nanoparticles with an absorption wavelength
of 525 nm were purchased from NANOCS in a 0.05% (w/v) and in PBS buffer, 0.1% BSA, and
10% Glycerol at pH 7.4. The stock solution, as calculated, is ~5 x 1013 particles/mL. Prior to
use, the SA-Au Nanoparticles were diluted to various concentrations depending on the
experimental conditions and analysis. Concentrations range from 10xs diluted SA-Au NPs with
0.1 mM HEPES buffer, pH 7.4 (~5 x 1012 particles/mL) to 1000xs diluted to a final concentration
of ~5 x 109 particles/mL*. After the desired dilution, particles were allowed to equilibrate in
solution for ~45 minutes prior to use.
For Synchrotron SAXS, the high concentration of SA-AuNPs refers to 5 x 1013 particles/mL,
whereas the low concentration of SA-AuNPs refers to 5 x 1012 particles/mL. For time-resolved
fluorescence and steady-state approximation experiments involving FITC, the [SA-AuNPs] is 5 x
1013 particles/mL.

For time-resolved fluorescence studies involving SA-QD525 with and

without B877, the concentration of SA-AuNPs was based on the ratio between QD and Au
needed (1:1, 1:0. 75, 1:0.50, and 1:0.25). For a 1:1 ration, [SA-AuNPs] 5 x 1011 particles/mL; for
1:0.75, [SA-AuNPs] is 3.75 x 1011 particles/mL; for 1:0.5, [SA-AuNPs] is 2.5 x 1011
particles/mL; for 1:0.25, [SA-AuNPs] is 1.25 x 1011 particles/mL.
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5.8.3 Preparation of Multicomponent System Comprised of Streptavidin Conjugated
Gold Nanoparticles, Fluorescein Isothiocyanate Organic Dye and Genetically
Engineered B877
	
  

Initially, the multicomponent system studies involved 10 nm Streptavidin Conjugated Gold
Nanoparticles (SA-AuNPs), Fluorescein-Isothiocyanate (FITC) and genetically engineered triple
helical peptide B877. Firstly, SA-AuNPs and FITC were selected due to their overlap of their
absorption (525 nm) and emission (518 nm) spectra, respectively. Prior to incubation with B877,
the covalent linking of SA-AuNPs and FITC was attempted through use of the gold-sulfur
interaction.
Fluorescein isothiocyanate (FITC) was purchased from Sigma Aldrich (MW= 389.38 g/mol,
λem= 518 nm) was dissolved in DMSO and diluted to a concentration of 14 µg/mL.

As

previously noted, the SA-AuNPs stock solution includes 0.1% Bovine Serum Albumin (BSA).
BSA is a fairly large protein that is 607 amino acids in length and has a weight of 66.5 kDa. With
that idea in mind, it was thought that the presence of this protein could inhibit or at least lessen
the number of FITC being able to bind to SA-AuNPs. As a result, solutions comprised of 60%
and 20% sucrose in D2O were used, along with centrifugation, to aid in the separation of BSA
from the SA-AuNPs. In the centrifuge tube, 50 µL of 60% sucrose (D2O) was pipetted, followed
by a less dense solution of 200µL 20% sucrose (D2O). Lastly, 50 µL of SA-AuNPs (with BSA)
was pipetted on top. The tube was then centrifuged for 90 minutes. Following centrifugation, the
SA-AuNPs should theoretically fall to the bottom of the tube within the 60% sucrose solution.
On top of that solution, should be the 20% sucrose solution, which is acting as the barrier
between the BSA molecules and the SA-AuNPs. Lastly, the BSA is suspended on top of the 20%
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sucrose solution. The SA-AuNPs are carefully pipetted out of the solution and used for sample
preparation.
Subsequently, samples were prepared for steady-state approximation and time-resolved
experiments: (1) FITC at a concentration of 484 ng/mL; (2) FITC + SA-AuNP at a 15:1 Molar
Ratio, where concentration of SA-AuNPs is 5x1013 particles/mL; (3) FITC + SA-AuNP + B877
at a 1:1:2 Volume Ratio, where the concentration of B877 is ~40 µg/mL.
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5.8.4. Preparation of 10 nm Streptavidin Conjugated Quantum Dots
	
  

10 nm Streptavidin Conjugated CdSe/ZnS Quantum Dots, with an emission wavelength
of 525 nm (SA-QD525) were purchased from Invitrogen. SA-QD525 stock solution is received
in a 1µM solution containing 1M betaine, 50 mM borate, pH 8.3 with 0.05% sodium azide. The
stock solution undergoes dialysis to exchange the buffer to 0.1 mM HEPES, pH 7.4. As with the
SA-AuNPs, the SA-QD525 solution is allowed to equilibrate for ~45 minutes prior to use. For
all time-resolved fluorescence samples, [SA-QD525] is 5 x 1011 particles/mL.
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5.8.5. Steady-State Fluorescence & Time-Resolved Fluorescence

For time-resolved fluorescence and steady-state approximation with FITC and SAAuNPs, [B877] is ~40 µg/mL. For time-resolved fluorescence with SA-QD525 and SA-AuNP,
the concentration is ~400 µg/mL for all experiments. For Synchrotron SAXS experiments, the
concentration of B877 is ranging from 5 mg/mL (high concentration), to 500 µg/mL (10xs
diluted), to 50 µg/mL B877 (low concentration; 100xs diluted). All experiments were done in
solution phase utilizing the Horiba Jobin Yvon Fluorog-3 instrument (right angle mode) and the
Fluorog-3 Time Correlated Single Photon Counting (TCSPC) instrument. The 401 nm laser
(NanoLED) is used and the sample is excited at such a wavelength. The raw data was then fitted
using the Data Analysis Program to either a bi-exponential or a tri-exponential fit, taking into
account the low XSQ value.
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5.8.6. Synchrotron Small-Angle X-ray Scattering
	
  
All Synchrotron Small-Angle X-Ray Scattering measurements were taken at Argonne
National Laboratory (APS 12ID-B) using the Pilatus2M detector.

Samples analyzed were

prepared at the facility. Data Collection time was < 1.00 second and 14 keV X-rays were used.
Also, dark frames were not subtracted, but the scattering from buffer and peptides was nonnegligible. Therefore, the buffer scattering was (in many cases) subtracted from the nanoparticle
aggregate scattering.
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